# chatGPT 分析报告
## 一、论文概况

---



### 标题

Hydrogels for RNA delivery

### 收录会议或期刊

Nature Materials

### 作者

Ruibo Zhong, Sepehr Talebian, Bárbara B. Mendes, Gordon Wallace, Robert Langer, João Conde, Jinjun Shi

### 摘要

RNA-based therapeutics have shown tremendous promise in disease intervention at the genetic level, and some have been approved for clinical use, including the recent COVID-19 messenger RNA vaccines. The clinical success of RNA therapy is largely dependent on the use of chemical modification, ligand conjugation or non-viral nanoparticles to improve RNA stability and facilitate intracellular delivery. Unlike molecular-level or nanoscale approaches, macroscopic hydrogels are soft, water-swollen three-dimensional structures that possess remarkable features such as biodegradability, tunable physiochemical properties and injectability, and recently they have attracted enormous attention for use in RNA therapy. Specifically, hydrogels can be engineered to exert precise spatiotemporal control over the release of RNA therapeutics, potentially minimizing systemic toxicity and enhancing in vivo efficacy. This Review provides a comprehensive overview of hydrogel loading of RNAs and hydrogel design for controlled release, highlights their biomedical applications and offers our perspectives on the opportunities and challenges in this exciting field of RNA delivery.

RNA基因治疗在疾病干预方面表现出巨大的潜力，其中一些已经获得临床使用的批准，包括最近的COVID-19信使RNA疫苗。RNA治疗的临床成功在很大程度上取决于化学修饰、配体偶联或非病毒纳米粒子来改善RNA的稳定性和促进细胞内递送。与分子水平或纳米尺度方法不同，宏观水凝胶是一种柔软的、含水的三维结构，具有可降解性、可调控的物理化学性质和可注射性等显著特点，最近它们在RNA治疗中引起了极大的关注。具体而言，水凝胶可以被设计成对RNA治疗药物的释放施加精确的时空控制，潜在地减少全身毒性并增强体内功效。该综述提供了RNA在水凝胶中的加载和控释设计的全面概述，突出了其生物医学应用，并提供了我们在这个令人兴奋的RNA递送领域的机遇和挑战的观点。

### 作者单位

1. Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
2. Faculty of Engineering, School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales, Australia.
3. Nano Institute (Sydney Nano), The University of Sydney, Sydney, New South Wales, Australia.
4. ToxOmics, NOVA Medical School Faculdade de Ciências Médicas, NMS FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
5. ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM, Innovation Campus, University of Wollongong, North Wollongong, New South Wales, Australia.
6. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
7. Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

### 作者邮箱

joao.conde@nms.unl.pt; jshi@bwh.harvard.edu

---



## 二、论文翻译



## 

---

 ## 原文[0/77]： 

 

 Ruibo Zhong1,8, Sepehr Talebian    2,3,8, Bárbara B. Mendes    4,8,  Gordon Wallace    5, Robert Langer    6,7, João Conde    4   & Jinjun Shi    1 

 RNA-based therapeutics have shown tremendous promise in disease  intervention at the genetic level, and some have been approved for clinical  use, including the recent COVID-19 messenger RNA vaccines. The clinical  success of RNA therapy is largely dependent on the use of chemical  modification, ligand conjugation or non-viral nanoparticles to improve  RNA stability and facilitate intracellular delivery. Unlike molecular-level  or nanoscale approaches, macroscopic hydrogels are soft, water-swollen  three-dimensional structures that possess remarkable features such as  biodegradability, tunable physiochemical properties and injectability, and  recently they have attracted enormous attention for use in RNA therapy。  

---

 ## 翻译[0/77]：
 

 RNA基因治疗在疾病干预方面已经展示出巨大的潜力，并且一些已被批准临床使用，包括最近的COVID-19信使RNA疫苗。RNA治疗的临床成功在很大程度上依赖于使用化学修饰、配体偶联或非病毒纳米颗粒来改善RNA稳定性并促进细胞内递送。与分子级或纳米尺度方法不同，宏观水凝胶是软性、水肿的三维结构，具有可降解性、可调节的物理化学性质和可注射性等显著特点，最近它们在RNA治疗中引起了极大的关注。

## 

---

 ## 原文[1/77]： 

   Specifically, hydrogels can be engineered to exert precise spatiotemporal  control over the release of RNA therapeutics, potentially minimizing systemic  toxicity and enhancing in vivo efficacy. This Review provides a comprehensive  overview of hydrogel loading of RNAs and hydrogel design for controlled  release, highlights their biomedical applications and offers our perspectives  on the opportunities and challenges in this exciting field of RNA delivery.

 Nucleic-acid-based therapies, such as DNA, antisense oligonucleotides  (ASOs), small interfering RNAs (siRNA) and messenger RNAs (mRNA),  have been widely used in diverse biomedical applications. As a type of  nucleic acid essential for all known life, RNA molecules play numerous  regulatory roles, such as instructing protein expression and modulating  targeted genes1–3. So far, several RNA therapeutics, mainly siRNA and  mRNA, have been clinically approved for different diseases (Table 1),  with many others in clinical trials. mRNA helps the body make its own  missing, defective or functional exogenous proteins (for example, anti gens)4, while siRNA reduces the expression of endogenously expressed  proteins or pathological proteins5。  

---

 ## 翻译[1/77]：
 

 氢凝胶在RNA递送中的应用

具体来说，氢凝胶可以被设计成在释放RNA治疗剂方面具有精确的时空控制能力，从而可能最小化系统毒性并提高体内的功效。本综述全面介绍了RNA的氢凝胶载荷和氢凝胶设计的控释方法，重点介绍了它们在生物医学领域的应用，并提供了我们对RNA递送这一激动人心领域的机遇和挑战的见解。



### 核酸治疗



核酸基因治疗，如DNA、反义寡核苷酸（ASOs）、小干扰RNA（siRNA）和信使RNA（mRNA），已被广泛应用于各种生物医学领域。作为所有已知生命的重要核酸类型，RNA分子发挥着众多调控作用，如指导蛋白质表达和调节靶向基因[1-3]。迄今为止，已经有一些RNA治疗药物，主要是siRNA和mRNA，已经在不同疾病中获得了临床批准（表1），还有许多药物正在临床试验中。mRNA有助于身体制造自身缺失、缺陷或功能异常的外源性蛋白质（例如抗原）[4]，而siRNA可以减少内源表达的蛋白质或病理性蛋白质的表达[5]。



## 

---

 ## 原文[2/77]： 

  Additionally, microRNAs (miRNAs)  and other non-coding RNAs have also been explored for regulating  gene expression at the post-transcriptional level6. Despite the considerable therapeutic potential of RNAs, limita tions on their in vivo delivery have been reported, including enzymatic  susceptibility, extracellular and cellular barriers, and difficulties in  trafficking to the subcellular compartment where the cargo will  be active1. Therefore, the majority of clinical-stage RNA therapies   are based on chemical modification (for example, phosphorothioate  linkage), ligand conjugation (for example, N-acetylgalactosamine   (GalNAC)) or non-viral nanoparticle (NP) delivery (for example, lipid  NP)7. Specifically, chemical modification improves enzymatic and  metabolic stability8, and ligand conjugation improves delivery to spe cific organs and cell types9. Finally, NPs protect encapsulated RNA and  improve pharmacokinetics and endosomal escape10。  

---

 ## 翻译[2/77]：
 

 进一步地，已经开始探索微小RNA (miRNA) 和其他非编码RNA在转录后调控基因表达的作用（6）。尽管RNA具有相当大的治疗潜力，但在体内传送方面有一些限制报告，包括酶敏感性、细胞外和细胞内屏障以及难以到达亚细胞室（其载体将发挥作用）的困难 (1)。因此，目前大多数临床阶段的RNA治疗方法是基于化学修饰（例如磷酸硫酸酯键）、配体结合（例如N-乙酰半乳糖胺 (GalNAC)）或非病毒纳米颗粒 (NP) 输送（例如脂质纳米颗粒） (7)。化学修饰能够提高RNA的酶和代谢稳定性 (8)，配体结合能够提高RNA传送到特定器官和细胞类型 (9)。最后，纳米颗粒可以保护封装的RNA，提高药代动力学和溶酶体逃逸 (10)。

## 

---

 ## 原文[3/77]： 

  However, these  delivery methods have their own limitations, with further improve ments needed for transfection efficiency11, organ/cell delivery speci ficity12, RNA stability13 and circumventing immune activation14, which  may require the development of entirely different categories of delivery  systems. Along these lines, substantial efforts have recently been made 

 Received: 6 January 2021 Accepted: 9 January 2023 Published online: 20 March 2023  Check for updates Nature Materials | Volume 22 | July 2023 | 818–831 819

 for the encapsulation of RNAs and other nucleic acids in hydrogels46.  However, synthetic polycations may cause moderate-to-high toxicity,  mainly due to their high positive charge. Further, synthetic cationic  polymers generally have a low molecular weight and a highly branched  structure, which may limit their potential applications in hydrogel  formation. Thus, conjugation of synthetic and natural polycations to  hydrogels or the use of hydrogels solely based on natural polycations  emerged to address these concerns37,47。  

---

 ## 翻译[3/77]：
 

 然而，这些运输方法都有各自的局限性，需要进一步改进以提高转染效率[11]，器官/细胞传递特异性[12]，RNA稳定性[13]和规避免疫激活[14]，可能需要开发完全不同种类的输送系统。沿着这个方向，最近已经做出了相当多的努力，用于在水凝胶中封装RNA和其他核酸[46]。然而，合成阳离子可能会引起中度到高度的毒性，主要是由于其高正电荷。另外，合成阳离子聚合物通常具有较低的分子量和高度分支的结构，这可能限制它们在水凝胶形成中的潜在应用[47]。因此，合成和天然阳离子与水凝胶的共轭或仅基于天然阳离子的水凝胶的使用应运而生，以解决这些问题[37]。

## 

---

 ## 原文[4/77]： 

  For example, several different  biodegradable polymers and fabrication systems were studied for  localized delivery of naked siRNA: calcium crosslinked alginate, photo crosslinked alginate and acid-solubilized collagen47. siRNA was rapidly  released within a week from the highly negatively charged alginate  hydrogels, but required over two weeks to be released from the collagen  hydrogel due to the effect of the amine groups. The incorporation of  positively charged polyethylenimine (PEI) or chitosan further delayed  siRNA release. Moreover, ionic bonds are susceptible to pH changes,  which may hinder the sustained release of the loaded biomolecules.  Factors such as the number and type of charge groups (for example,  primary, secondary and quaternary amino groups and amidine groups)  per single polymer can also help determine the ultimate release profile. Hydrogen bond. Neutrally charged polymers such as polyvinyl alcohol  (PVA) can bind to nucleic acids through the interaction of the positive  hydrogen atom, which establishes an electrostatic link with electron egative acceptor atoms48。  

---

 ## 翻译[4/77]：
 

 不同的生物可降解聚合物和制备系统被研究用于裸siRNA的局部释放：包括钙交联海藻酸盐、光交联海藻酸盐和酸溶性胶原蛋白47。高负电荷的海藻酸盐水凝胶在一周内快速释放siRNA，而胶原蛋白水凝胶需要两周以上才能释放，这是由胺基团的影响所导致的。添加带正电荷的聚乙烯亚胺（PEI）或壳聚糖进一步延缓了siRNA的释放。此外，离子键易受pH变化的影响，这可能会阻碍载药生物分子的持续释放。聚合物的带电基团数量和类型（例如，一次性、二次性、季铵和酰胺基团）也有助于确定最终的释放特性。氢键。中性的聚乙烯醇（PVA）可以通过正氢原子的作用与核酸结合，与负电子受体原子建立静电连接48。

## 

---

 ## 原文[5/77]： 

  Such polymers can be further modified  with certain chemical moieties to increase intermolecular hydrogen  bonding interactions between the hydrogel and the RNAs. Similarly,  negatively charged polysaccharides such as alginate and hyaluronic  acid (HA) have been explored to promote the controlled release of  RNAs, which can also be modified with additional moieties to increase  the number of hydrogen bonds to the encapsulated nucleic acids.  For example, HA-PVA hydrogels were shown to release siRNA in vitro  more slowly than PVA hydrogels, which was attributed to a higher  number of hydrogen bonds between the siRNA and the HA backbone49.  It is important to emphasize that hydrogen bonds are primarily weak  electrostatic interactions, which may not induce strong binding of  RNAs to the hydrogels. Consequently, hydrogen and ionic bonds are  sometimes combined to boost interactions between the hydrogel and  RNAs, through the addition of cationic molecules or polymers to the hydrogel formula39,50.

 Covalent bond。  

---

 ## 翻译[5/77]：
 

 改善RNA在水凝胶中的控制释放性质这些聚合物可以通过与特定化学官能团的修饰进一步改良，从而增强水凝胶与RNA之间的分子间氢键相互作用。同样，阴离子聚糖如海藻酸盐和透明质酸（HA）已被研究用于促进RNA的控制释放，还可以通过添加附加官能团来增加与包裹核酸的氢键数量。例如，HA-PVA水凝胶在体外显示出比PVA水凝胶更缓慢地释放siRNA的特性，这被归因于siRNA与HA骨架之间更多的氢键数量49。需要强调的是，氢键主要是弱的静电相互作用，可能不能引起RNA与水凝胶之间的强结合。因此，有时需要将氢键与离子键结合起来，通过向水凝胶配方中添加阳离子分子或聚合物，以增强水凝胶与RNA之间的相互作用39,50。



### 共价键。



## 

---

 ## 原文[6/77]： 

  Covalent conjugation of RNAs to the backbone   of hydrogels allows for the homogeneous and predictable distribu tion of a large quantity of RNAs with minimal initial burst release.   Although this method is very common in small-molecule drug deliv ery, there are very few examples of covalently binding RNAs51. For  instance, siRNA was covalently tethered to the photocrosslinked  to explore the use of macroscale hydrogels for RNA-based therapeu tics delivery, as well as a variety of biomedical applications ranging   from gene silencing and protein replacement to immunomodulation (Fig. 1)15–40.

 Hydrogels are composed of a water-swollen three-dimensional  network that recapitulates the intrinsic properties of the native extra cellular matrix (ECM), making them useful for applications in tissue  engineering, drug delivery, cellular morphogenesis, among others41,42。  

---

 ## 翻译[6/77]：
 

 RNAs与水凝胶的背骨的共有键合允许大量的RNAs均匀且可预测地分布，同时仅有最小量的初期迅速释放。尽管这种方法在小分子药物输送中非常常见，但是只有极少数共有键合RNA的例子51。例如，siRNA被共有键合到光交联的水凝胶中，用于探索基于RNA的治疗输送的宏观水凝胶的应用，以及从基因沉默、蛋白质替代到免疫调节等各种生物医学应用（图1）15–40.

水凝胶由水肿胀的三维网络组成，重现了天然细胞外基质（ECM）的固有属性，使其在组织工程、药物输送、细胞形态发生等应用中非常有用41,42。



## 

---

 ## 原文[7/77]： 

   The unique physicochemical features of hydrogels allow the mainte nance of RNA biological activity, the retention and sustained release  of RNA as local delivery carriers (for example, injectable systems),  and the delivery of high concentrations of payloads to a target site  in an on-demand/pulsatile manner via stimuli-responsive strategies   (Fig. 2)43,44. Thus, hydrogels could improve RNA stability, reduce unnec essary loss of therapeutics associated with systemic delivery, mitigate  undesirable off-target toxicities and avoid the necessity of multiple  doses. All of these make hydrogels an appealing system for RNA-based  therapeutics delivery, complementary to the clinical-stage platforms mentioned above.

 Compelling evidence supporting the application of hydrogels  for delivery of RNAs and other nucleic acids has been gathered ever  since the first use of polymer pellets for sustained nucleic acid release  in 197645. This Review aims to summarize RNA-loading strategies in  hydrogels, discuss the design of hydrogels for controlled delivery  of RNAs, highlight recent progress in biomedical applications, and  provide perspectives on the challenges and opportunities in this blos-soming research field.
  

---

 ## 翻译[7/77]：
 

 独特的物理化学特性水凝胶的独特的物理化学特性使其能够维持RNA生物活性，将RNA作为局部递送载体（例如，可注射系统）进行保留和持续释放，并通过刺激响应策略以按需/脉冲方式将高浓度的药物递送到靶位点（如图2）[43, 44]。因此，水凝胶可以提高RNA的稳定性，减少与全身递送相关的药物疗效不必要的损失，减轻非预期的非靶靶向毒性，并避免多次投药的必要性。所有这些特点使得水凝胶成为RNA药物递送的有吸引力的系统，与上述临床阶段的平台相辅相成。



自1976年首次使用聚合物颗粒进行持续核酸释放以来，已经积累了以水凝胶为载体递送RNA和其他核酸的有力证据[45]。本综述旨在总结水凝胶中的RNA装载策略，讨论设计用于RNA控制性递送的水凝胶，突出生物医学应用的最新进展，并提供对于这个蓬勃发展的研究领域的挑战和机遇的展望。



## 

---

 ## 原文[8/77]： 

  RNA can be loaded into hydrogels either by direct inclusion of the naked  RNA or by encapsulating RNA nanocarriers (Fig. 3). The loading of naked  RNA largely depends on the physicochemical interactions between the  RNA and the hydrogel network. As a comparison, nanocarriers may  offer improved RNA bioactivity, better controllability of RNA release  and targeting of specific cells, while the loading is dependent on the interactions of nanocarriers with the hydrogel.

 Multiple strategies have been developed for loading naked RNAs into  hydrogels, such as electrostatic interaction, covalent conjugation, 

 duce each strategy and the associated hydrogels, and discuss their features for delivery of naked RNA.

 Ionic bond. Cationic/ionizable polymers and lipids, the most widely  studied non-viral delivery materials, can interact with negatively  charged biomolecules, making ionic bonds a simple and robust method 

 Table 1 | RNA therapeutics approved for clinical use Nature Materials | Volume 22 | July 2023 | 818–831 820

 dextran hydrogels via Michael-addition chemistry。  

---

 ## 翻译[8/77]：
 

### RNA的加载方式



RNA可以通过直接将裸露的RNA包含在水凝胶中，或通过封装RNA纳米载体来加载（图3）。裸露RNA的加载主要取决于RNA与水凝胶网络之间的物理化学相互作用。相比之下，纳米载体可以提供改善的RNA生物活性，更好地控制RNA的释放和靶向特定细胞的能力，但其加载取决于纳米载体与水凝胶之间的相互作用。



 裸露RNA的加载策略

已经发展了多种策略将裸露RNA加载到水凝胶中，例如静电相互作用、共价结合、离子键。阳离子/可离子化聚合物和脂质是最广泛研究的非病毒传递材料，它们可以与带负电的生物分子发生作用，这使离子键成为一种简单且可靠的方法。



 RNA治疗的临床使用批准表

表1 | RNA治疗在临床上的批准使用 Nature Materials | Volume 22 | July 2023 | 818–831 820



 迈克尔加成化学方法用于葡聚糖水凝胶的制备。

## 

---

 ## 原文[9/77]： 

  Upon hydrolytic  degradation of ester and/or disulfide linkages, the profile release of  siRNA was prolonged up to 10 days in comparison with the unbound  compound that was released in the first 12 hours. By tailoring the  degradable linkages or the amount of tethered siRNA in the hydrogel  network is possible to control the cargo amount and its profile release.  However, the conjugation of siRNA into the hydrogel network possesses additional technical complexity.

 Hydrophobic interaction. Hydrophobic interactions occur through  the formation of a clathrate cage, an ice-like matrix of water mole cules formed through hydrogen bonds, around the hydrophobe52.  The host–guest pairs are relatively easy to synthesize and can interact  with biological molecules, being typically driven by molecule size  and hydrophobicity. Guest–host pairs are widely used for injectable  hydrogel fabrication mainly due to their dynamic bonds that, upon,  can reform44. For example, cyclodextrin (CD) showed relatively low  toxicity and high water solubility29, enabling a range of hydrophobic  guest molecules to be embedded in their interior cavities53。  

---

 ## 翻译[9/77]：
 

涉水解酯和/或二硫键的水解降解，与未结合的化合物相比，siRNA的释放剖面可延长至10天。通过调控可降解键或水凝胶网络中连接的siRNA的量，可以控制载荷量和其释放剖面。然而，将siRNA共轭到水凝胶网络中具有额外的技术复杂性。

疏水作用。疏水作用通过形成一个水分子的冰状晶格，即水合壳，围绕着亲疏水子发生。亲疏水宾宾对相对容易合成，且能够与生物分子相互作用，通常由分子大小和疏水性驱动。宾宾宾宾对主要用于可注射水凝胶的制备，因为其动态键可以再组装。例如，环糊精（CD）显示出相对较低的毒性和高的水溶性，可嵌入其内部空腔中的一系列疏水宾宾29。

## 

---

 ## 原文[10/77]： 

  HA was  modified with CD, as a host, or with adamantane, as a guest, which were  self-assembled into injectable hydrogels. The HA assembly system  enables the formation of complex CD-cholesterol-modified miR-302  interactions for miRNA local and sustained release40. The release of  miRNA from the HA hydrogel network is measured over three weeks  (in vitro studies), and it is faster than the erosion of the hydrogel. Thus,  it is hypothesized that miRNAs diffuse from the hydrogel network,  highlighting the crucial role of the anionic repulsion of HA to miRNA and the hydrogel guest–host interactions.

 As an alternative approach, supramolecular hydrogels can also be  formed by self-assembly of biocompatible small-molecule hydrogela tors, which is triggered by intramolecular π–π stacking of hydrogelator  molecules and RNAs. For example, polyethylene glycol (PEG) modified  with ureido-pyrimidinone moieties (UPy-PEG) was able to dimerize  in water, producing a fibrous supramolecular hydrogel54。  

---

 ## 翻译[10/77]：
 

 HA的修饰和超分子水凝胶的形成用CD修饰了HA作为宿主，或者用金刚烷修饰了HA作为客体，它们在自我组装成可注射的水凝胶。HA组装系统可以形成复杂的CD-胆固醇修饰的miR-302相互作用，并实现miRNA的局部和持续释放40。通过三周的体外研究，HA水凝胶网络中miRNA的释放速度比水凝胶的腐蚀速度更快。因此，假设miRNA从水凝胶网络中扩散出来，突出了HA对miRNA的负离子排斥和水凝胶客体-宿主相互作用的关键作用。



作为一种替代方法，超分子水凝胶也可以通过生物相容性小分子水凝胶体的自组装来形成，该过程是由水凝胶体内的π-π堆积作用触发的。例如，聚乙二醇(PEG)修饰了尿浅蓝嘌呤酮基团(UPy-PEG)，它能够在水中发生二聚作用，产生纤维状的超分子水凝胶54。



## 

---

 ## 原文[11/77]： 

  siRNA and  miRNA were covalently conjugated with cholesterol to directly inter act with the hydrophobic core of the fibre, which fine-tunes siRNA  and miRNA profile release. Otherwise, supramolecular hydrogelator  molecules (for example, tetrazole and spiropyran) can be added to  facilitate hydrophobic interactions with the hydrophobic side chains  of amino acids within the encapsulated RNA structures55. However,  in these hydrogels the ratio of hydrophobic moieties to hydrophilic  regions must be adjusted carefully to preserve water-uptake capacity. It  should also be noted that such hydrophobic interactions do not depend  on RNA itself but on the hydrophobic modifier on RNA. Non-specific interaction. In some cases, RNA loading in hydrogels is  merely mediated by non-specific interactions. The RNA release may  therefore be governed simply by diffusion-controlled mechanisms,  Nature Materials | Volume 22 | July 2023 | 818–831 821

 which are discussed in detail in the following section。  

---

 ## 翻译[11/77]：
 

 利用胆固醇与siRNA和miRNA进行共价结合，直接与纤维的疏水核心相互作用，从而精确调节siRNA和miRNA的释放情况。此外，可以添加超分子水凝胶剂分子（例如四唑和螺环聚苯），以促进与封装的RNA结构中的疏水侧链的疏水相互作用。然而，在这些水凝胶中，疏水基团与亲水区域的比例必须小心调整，以保持吸水能力。值得注意的是，这种疏水相互作用不仅仅依赖于RNA本身，而是依赖于RNA上的疏水修饰剂。在某些情况下，RNA在水凝胶中的装载仅仅是由非特异性相互作用介导的。因此，RNA的释放可能仅受扩散控制机制的调控，下一节将对此进行详细讨论。

## 

---

 ## 原文[12/77]： 

  For instance, one  could increase the crosslinking density and consequently decrease the  swelling and drug release rate, or reduce the macromolecular mesh size  by altering the macromolecular structure and therefore extend the  drug release time. This is often the case for thermo-sensitive hydrogels,  such as poly(N-isopropylacrylamide)56, which can be formed upon  in vivo administration, instigated by the sol-to-gel phase transition.  A major limitation associated with thermohydrogels is their lack of  biodegradability, which could be addressed by copolymerizing them  with biodegradable polymers. The limited control over the RNA release  profile may be further overcome by the incorporation of cationic polymers.

 The delivery of RNA nanocarriers (for example, liposomes/lipid NPs,  polymeric NPs and inorganic nanomaterials) loaded within a hydrogel 

 Review article 

https://doi.org/10.1038/s41563-023-01472-w network could avoid the chemical modification of both RNA and hydro gel polymers and improve loading, stability and transfection efficiency  compared with naked RNA strategies (Fig。  

---

 ## 翻译[12/77]：
 

 递送RNA纳米载体（例如，脂质体/脂质纳米颗粒、聚合物纳米颗粒和无机纳米材料）负载在一种水凝胶网络内例如，可以通过增加交联密度并因此降低肿胀和药物释放速率，或通过改变大分子结构从而减小大分子网孔尺寸，从而延长药物释放时间。这在温敏水凝胶中经常发生，如聚N-异丙基丙烯酰胺(PNIPAM)，该水凝胶可在体内给予后通过溶胶-凝胶相变形式形成。与温敏水凝胶相关的一个主要限制是它们缺乏可降解性，这可以通过与可降解聚合物共聚合来解决。通过引入阳离子聚合物可以进一步克服对RNA释放特性的有限控制。



该网络内的RNA纳米载体的递送（例如，脂质体/脂质纳米颗粒、聚合物纳米颗粒和无机纳米材料）可以避免对RNA和水凝胶聚合物的化学修饰，并且与裸RNA策略相比，可以提高载荷、稳定性和转染效率（图）。



# 综述文章



链接：https://doi.org/10.1038/s41563-023-01472-w



## 

---

 ## 原文[13/77]： 

  3)3. Below, we outline the  loading of several representative RNA nanocarriers in hydrogels. Lipid nanocarrier. Cationic/ionizable lipids can be used in the form  of either liposomes or RNA/lipid complexes, such as lipoplexes and  niosomes57. Fibrin gels are capable of supporting cell migration while  maintaining lentivirus activity58. Fibrin-based hydrogel surface was  conjugated with siRNA-loaded lipofectamine to increase its cellu lar internalization levels and knock down antagonists (for example,  noggin)59. Approximately 20% of free siRNA or siRNA complexed  with lipofectamine was remained on the fibrin surface after 3 days,  therefore indicating that the negative charge of fibrin does not appear  to influence the surface retention of nanocomplexes. On the other  hand, the use of injectable chitosan–alginate scaffolds containing  mRNA–lipoplexes demonstrated the ability to induce an in vivo local  transfection and increase antibody production and T-cell prolifera tion levels when compared with the systemic administration of only  mRNA–lipoplexes60。  

---

 ## 翻译[13/77]：
 

 RNA纳米载体的加载在下面，我们将概述几种代表性的RNA纳米载体在水凝胶中的加载。脂质纳米载体。阳离子/电离性脂质可以以脂质体或RNA/脂质复合物（如脂质复合物和非脂质体）的形式使用57。纤维蛋白凝胶可以支持细胞迁移，同时保持慢病毒活性58。纤维蛋白基水凝胶表面与负载siRNA的脂质体素共轭，以提高其细胞内摄取水平并抑制拮抗剂的表达（例如noggin）59。大约20%的游离siRNA或与脂质体素结合的siRNA在3天后仍然保留在纤维蛋白表面上，因此表明纤维蛋白的负电荷似乎不影响纳米复合物的表面保留。另一方面，使用含mRNA-脂质体素的可注射壳聚糖-藻酸盐支架显示了诱导体内局部转染和增加抗体产生和T细胞增殖水平的能力，与仅体内给予mRNA-脂质体素相比60。



## 

---

 ## 原文[14/77]： 

  Notably, there is still a limited number of pub lished studies using RNA–liposome-loaded hydrogels, which might  be explained by the thermodynamic instability of liposomes and their further aggregation in a charged hydrogel61.

 Polymer nanocarrier. Cationic polymers such as polyethylenimine  (PEI) chitosan, and poly(l-lysine) (PLL) are often used to create poly plexes62. Unlike lipid-based nanocarriers, cationic polymers are com pletely soluble in water due to their general absence of hydrophobic  moieties46. Moreover, cationic polymers have the ability to compress  nucleic acids to a smaller size than cationic lipids. One potential  disadvantage of RNA–polymer nanocarriers is that, for some soft  and charged NPs, aggregation could occur during loading, which  may limit the amount of RNA that can be loaded into the hydrogel63.  Collagen-based hydrogels, which closely resemble natural ECM, have  been used for local delivery of RNA nanocomplexes。  

---

 ## 翻译[14/77]：
 

 RNA脂质体水凝胶的限制

值得注意的是，使用RNA脂质体水凝胶的研究仍然很有限，这可能是由于脂质体的热力学不稳定性以及在带电水凝胶中的进一步聚集所解释的52。



### 聚合物纳米载体



阳离子聚合物，如聚乙烯亚胺（PEI）、壳聚糖和聚赖氨酸（PLL），常用于生成聚合物复合物52。与基于脂质的纳米载体不同，阳离子聚合物由于普遍缺乏疏水基团，完全可溶于水46。此外，阳离子聚合物能够将核酸压缩成比阳离子脂类更小的尺寸。RNA-聚合物纳米载体的一个潜在缺点是，在某些软性和带电的纳米颗粒上，在装载过程中可能发生聚集，这可能会限制可以装载到水凝胶中的RNA的数量63。类似天然胶原基质的胶原水凝胶已被用于局部释放RNA纳米复合物。



## 

---

 ## 原文[15/77]： 

  One specific  collagen hydrogel was capable of sustained delivery of siRNA/PEI  nanocomplexes in vitro over 10 days32. However, the foreign proteins  in collagen hydrogels might elicit a foreign body response, which  could hinder their biological application64. Along these lines, HA-based  hydrogels may be one of the preferred choices for RNA delivery65.  Cyclooxygenase-engineered miRNA (COX-1 and COX-2) plasmids were  loaded onto PLGA/PEI NP complexes, and then embedded in HA hydro gels65. A slower, more sustained release profile from the hydrogel was  detected compared with plasmid/NP complexes. Possible interactions  of polymeric nanocarriers with the hydrogel could affect the release  rate. In fact, aggregation and deactivation of RNA-loaded NPs within  hydrogels have been reported63. To address this, coating NPs with  agarose66, covalent attachment of NPs to the hydrogel backbone67 or  similar strategies may be applied in engineering such delivery systems. Inorganic nanocarrier。  

---

 ## 翻译[15/77]：
 

 一种特定的胶原蛋白水凝胶在体外能够持续释放siRNA/PEI纳米复合物长达10天32。然而，胶原蛋白水凝胶中的外源蛋白可能引发异物反应，这可能阻碍其生物应用64。在这方面，基于透明质酸（HA）的水凝胶可能是RNA传递的首选65。将环氧合酶工程miRNA（COX-1和COX-2）质粒装载到PLGA/PEI纳米颗粒复合物中，然后嵌入HA水凝胶中65。与质粒/纳米颗粒复合物相比，从水凝胶中检测到了较慢、更持久的释放特征。聚合物纳米载体与水凝胶的可能相互作用可能会影响释放速率。实际上，有人报道了水凝胶中RNA载荷的纳米颗粒的聚集和失活63。为了解决这个问题，可以将纳米颗粒与琼脂糖进行包覆66，或者将纳米颗粒共价连接到水凝胶骨架上67，或者采用类似的策略来设计这种传递系统。无机纳米载体。

## 

---

 ## 原文[16/77]： 

  Inorganic colloidal NPs (for example, gold,  iron oxide, silica and quantum dots) have been utilized in RNA therapy  mainly for their facile synthesis process and wide availability3. For  example, PEI-based hydrogels were conjugated with siRNA-Au-Fe3O4  nanocapsule. The subcutaneous administration of nanocapsule hydro gel demonstrated a better tumour penetration and a higher blood  circulation time compared with intravenous administration of nano capsule only22. Certainly, AuNPs allow a wide variety of functionaliza tions via gold–thiol conjugation, being broadly used in multi-modal  approaches68. Multifunctional quantum dot DNA hydrogels containing  doxorubicin and siRNA reduced EGFR expression significantly more  than siRNA alone69. Quantum dot DNA hydrogels are capable of func tioning as a delivery vector without toxic transfection agents and have  demonstrated high in vivo therapeutic efficacy against breast cancer.  Nature Materials | Volume 22 | July 2023 | 818–831 823
  

---

 ## 翻译[16/77]：
 

### 无机胶体纳米颗粒

无机胶体纳米颗粒(如金、铁氧化物、二氧化硅和量子点)主要被应用于RNA疗法中，这主要是因为它们的合成过程简单和易得3。例如，基于聚乙烯亚胺(PEI)的水凝胶被结合了siRNA-Au-Fe3O4纳米胶囊。与单独注射纳米胶囊相比，纳米胶囊水凝胶通过皮下注射显示出更好的肿瘤渗透和更长的血液循环时间22。当然，AuNPs允许通过金硫醇共轭进行多样化功能化，广泛用于多模式方法68。多功能量子点DNA水凝胶含有阿霉素和siRNA，与单独的siRNA相比，显著降低EGFR的表达69。量子点DNA水凝胶能够在没有有毒转染试剂的情况下作为传递载体，并在体内对乳腺癌显示出高治疗效果。Nature Materials | Volume 22 | July 2023 | 818–831 823



## 

---

 ## 原文[17/77]： 

  The combination of inorganic core–hydrogel scaffolds with colloidal  NPs introduces the possibility of new scaffold structures with differ ent core size, charge, coatings and physical stretching/compression of hydrogels.

 depend on the target application. As a result, multiple hydrogel designs  have been employed to facilitate the controlled release of RNAs through  either passive or active mechanisms. While passive mechanisms can  enable continuous short and long-term release, active mechanisms can  yield pulsatile release patterns. In the following section, a comprehen sive review of these mechanisms for controlled release of naked RNAs  or RNA-nanocarriers from hydrogels is provided (Fig. 5).

 Continuous passive release from hydrogels is achieved by the individual  action or the combination of factors like diffusion, hydrogel network  degradation, and hydrogel swelling. On this account, passive release  can be adjusted by engineering hydrogel features such as molecular  weight, matrix concentration, crosslinking density, hydrophilicity and  pore size distribution33,70,71, in addition to the aforementioned hydrogel chemistries for interacting with RNAs.
  

---

 ## 翻译[17/77]：
 

 组合无机核-水凝胶支架与胶体纳米颗粒相结合引入了具有不同核大小、电荷、涂层和水凝胶物理拉伸/压缩的新型支架结构的可能性。

依赖于目标应用，为促进通过被动或主动机制控制释放RNA，使用了多种水凝胶设计。虽然被动机制可以实现持续的短期和长期释放，但主动机制可以产生脉冲式的释放模式。下一部分将提供对这些机制进行全面回顾，用于从水凝胶中控制裸核RNA或RNA纳米载体的释放（图5）。



通过扩散、水凝胶网络降解和水凝胶肿胀等因素的个别作用或组合，可以实现水凝胶的持续被动释放。为此，除了与RNA相互作用的上述水凝胶化学反应外，还可以通过调控水凝胶特性，如分子量、基质浓度、交联密度、亲水性和孔径分布33,70,71，来调整被动释放。



## 

---

 ## 原文[18/77]： 

  Hydrolytically degradable functionalities, such as ester groups,  have been incorporated into the hydrogel backbone as a means  to control release rate72. To this end, based on thiol–ene interac tions, an hydrogel formed in situ was made using a combination of  eight-arm thiol-modified PEG (8-arm-PEG-SH) with either eight-arm  acrylic-modified PEG (8-arm-PEG-A) that contains one ester group on  each arm or eight-arm mono(2-acryloyloxyethyl) succinate-modified  PEG (8-arm-PEG-MAES) that contains three hydrolysable ester groups  on each arm73. The hydrogel with the higher ester linkages in the macro molecular networks (8-arm-PEG-MAES) exhibited faster swelling and  degradation, which induces a faster release of RNA-PEI nanocomplexes  (85.09 ± 2.43% over 19 days) compared with the other two hydrogel formulations.

 The release rate can be further tuned by adjusting the nanocarrier  size and concentration28。  

---

 ## 翻译[18/77]：
 

### 水解降解功能

水解降解功能，例如酯基团，已被引入到水凝胶的骨架中，以用于控制释放速率72。为此，基于硫醇-烯烃相互作用，使用八臂硫醇修饰的聚乙二醇（8-arm-PEG-SH）与含有一个酯基团的八臂丙烯酸酯修饰的聚乙二醇（8-arm-PEG-A）或含有三个可水解酯基团的八臂单(2-丙烯酰氧乙基)琥珀酸酯修饰的聚乙二醇（8-arm-PEG-MAES）结合，经原位聚合生成了一种水凝胶73。具有更多酯键的水凝胶（8-arm-PEG-MAES）在大分子网络中表现出更快的肿胀和降解速度，从而与其他两种水凝胶配方相比引起了RNA-PEI纳米复合物的更快释放（85.09%±2.43% 在19天内）。



### 控制释放速率

通过调整纳米载体的尺寸和浓度，释放速率可以进一步调节28。



## 

---

 ## 原文[19/77]： 

  Photocrosslinked DEX hydrogels (DEX-HEMA)  were covalently functionalized with cationic linear PEI methacrylate  (LPEI-GMA) via a biodegradable ester linkage74. siRNA electrostatically  interacts with the cationic linear PEI. Thus, siRNA profile release was  fine-tuned by the degradation rate of DEX-HEMA hydrogels via bio degradable ester linkages and the degree of siRNA/PEI interactions,  which were achieved by controlling the hydrogel (8 and 12 wt%) and/ or the nanocarrier (0, 5 and 10 μg) concentration. The hydrogels were  able to release the siRNA over long time periods (9 to 17 days). Remark ably, the observed sustained profile release of RNA from hydrogel  network over a long time period (weeks) can be detrimental to induce  a significant physiological response. Indeed, the low amount of RNA  that is released from the hydrogel network cannot be sufficient to  promote a target effect that systemic administration (or several local administrations) can achieve.
  

---

 ## 翻译[19/77]：
 

 光交联的DEX水凝胶(DEX-HEMA)通过可降解的酯键与阳离子线性PEI丙烯酸酯(LPEI-GMA)共价共功能化。siRNA与阳离子线性PEI静电相互作用。因此，通过控制水凝胶(8和12 wt%)和/或纳米载体(0、5和10 μg)浓度来调节DEX-HEMA水凝胶的降解速率和siRNA/PEI相互作用的程度，从而调控siRNA的释放。水凝胶能够在很长时间内释放siRNA (9到17天)。值得注意的是，观察到的RNA从水凝胶网络中持续释放的现象在长时间内（数周）可能对诱导重要的生理反应是有害的。实际上，从水凝胶网络中释放的RNA数量较少，不足以促使靶向效应，而通过全身给药（或几次局部给药）则可以实现这一效应。

## 

---

 ## 原文[20/77]： 

  To address the issues associated with passive release, on-demand  delivery of RNAs from the hydrogels has been achieved using active  mechanisms of release. Active release is achieved in response to inter nal (for example, pH and enzyme) or external stimuli (for example,  photoradiation), which can facilitate on-demand degradation of the  hydrogel network and hence promote RNA release. The trigger of RNA  release through external stimuli introduces additional control of RNA  delivery at defined doses and during specific periods, providing an  alternative to physician or patient-delivered strategies. pH-responsive release. pH-responsive hydrogels often contain  Schiff base bonds, which are stable at pH 7.4 but disrupted in an acidic  environment (for example, pH 6.8)75. Such hydrogels are suitable  for on-demand release of RNA in diseases associated with an acidic  tissue microenvironment (such as cancer and myocardial infarction  (MI)). For instance, a pH-sensitive hydrogel was created based on a  combination of miRNA-loaded amine-functionalized mesoporous  silica NPs (MSNs), aldehyde-functionalized PEG (PEGCHO) and α-CD76。  

---

 ## 翻译[20/77]：
 

 解决被动释放问题的方式是利用主动释放机制实现RNA从水凝胶中的即时传递。主动释放是通过对内部（比如pH和酶）或外部刺激（比如光辐射）作出反应来实现的，这些刺激可以促使水凝胶网络的即时降解，从而促进RNA的释放。通过外部刺激触发RNA释放引入了对RNA传递的额外控制，能在特定剂量和特定时间段内提供一种替代的由医生或患者进行的传递策略。

 pH响应释放。pH响应型水凝胶通常包含席夫碱键，它们在pH 7.4下稳定，在酸性环境（例如pH 6.8）下会被破坏。这样的水凝胶适合在与酸性组织微环境相关的疾病（比如癌症和心肌梗塞）中即时释放RNA。例如，基于miRNA载荷的胺基化介孔硅纳米颗粒（MSNs）、醛基化PEG（PEGCHO）和α-CD的组合制备了一种pH敏感的水凝胶。

## 

---

 ## 原文[21/77]： 

   The hydrogel fabrication relies on Schiff and hydrophobic interac tions between PEGCHO, α-CD and MSN. At a slightly acidic environment   (pH 6.8), Schiff base bonds are cleaved to produce an aldehyde  functional group, and MSN/miR-21-5p is released from the hydrogel   (75% for 1 week in vitro) to the infarct region. While at pH 7.4, only  6% of MSN/siRNA nanocomplexes were released from the hydrogel.  Interestingly, the amount of released RNA upon pH stimuli was effec-tive as an MI treatment.

 Enzyme-responsive release. Enzyme-sensitive hydrogels nor mally contain a polymeric network that is crosslinked with an  enzyme-sensitive peptide linker77. In the presence of a certain enzyme  (for example, matrix metallopeptidase 2 (MMP-2), protease, trypsin  and lysozyme) the peptide linker is broken, which leads to the release  of the entrapped RNA therapeutics from the hydrogels。  

---

 ## 翻译[21/77]：
 

### 羟基凝胶制备

羟基凝胶的制备依赖于PEGCHO、α-CD和MSN之间的席夫碱和疏水作用。在微酸性环境（pH 6.8）下，席夫碱键被断裂，产生醛基功能团，使MSN/miR-21-5p从羟基凝胶释放出来（在体外1周内释放75%），达到梗死区域。而在pH 7.4下，仅有6%的MSN/siRNA纳米复合物从羟基凝胶中释放出来。有趣的是，RNA的释放量对pH刺激具有有效的心肌梗死治疗作用。



### 酶诱导释放

酶敏感性羟基凝胶通常包含与酶敏感性肽连接物交联的聚合物网络。在特定酶的存在下（例如，基质金属蛋白酶2（MMP-2），蛋白酶，胰蛋白酶和溶菌酶），肽连接物被断裂，导致嵌入的RNA治疗物从羟基凝胶中释放出来。



## 

---

 ## 原文[22/77]： 

  Along these  lines, HA-based hydrogels were formed through hydrozone bonds  (that is, aldehyde-modified HA and hydrazide-modified HA) and pro tease degradable peptide crosslinkers78. Then, CD-modified HA was  introduced in the hydrogel system to sequester cholesterol-modified  siRNA, as previously described40. As expected, the hydrogel was  eroded and siRNA targeting MMP2 was released in response to pro tease (for example, collagenase) levels for MI treatment60. In another  study, an MMP-2 degradable hydrogel was loaded with tumour  growth factor-β1 siRNA polyplexes, which were further adsorbed  onto electrospun fibres79. High MMP-2 concentrations promoted  faster release of polyplexes due to the MMP-2 substrate peptide  degradation in the hydrogels, whereas the addition of MMP-2 had  almost no influence on siRNA release from the hydrogels containing MMP-2-nondegradable crosslinkers.

 Photo-triggered release. Light-responsive hydrogels offer  on-demand spatial and temporal control。  

---

 ## 翻译[22/77]：
 

 HA基水凝胶的形成沿着这些思路，通过氢键（即，醛基修饰的HA和肼基修饰的HA）和蛋白酶降解的肽交联剂 78，形成了基于HA的水凝胶。然后，如之前所描述的，引入了CD修饰的HA到水凝胶系统中，以富集胆固醇修饰的siRNA40。如预期的那样，水凝胶在酶解（例如，胶原酶）水平下被侵蚀，释放出针对MMP2的siRNA用于心肌梗死(MI)的治疗60。另外一项研究中，用MMP-2降解的水凝胶载入了抗肿瘤生长因子-β1 siRNA聚合物复合物，并进一步吸附在静电纺丝纤维上79。高MMP-2浓度促进了聚合物复合物的更快释放，这是由于水凝胶中MMP-2底物肽的降解，而MMP-2的添加几乎对含有MMP-2非降解交联剂的水凝胶中的siRNA释放没有影响。



### 光触发释放

光响应型水凝胶提供按需的空间和时间控制。



## 

---

 ## 原文[23/77]： 

  Generally, these hydrogels  contain single or multiple photocleavable moieties (for example,  nitrobenzyl-based linkers with ester or amide bonds) with variable  degradation properties in response to light wavelength and intensity,  as well as radiation time. While naked RNA is attached to the hydrogel  network via photolabile bonds, the RNA nanocarriers are encapsu lated in the hydrogel crosslinked by these photo-sensitive bonds.  Photodegradable PEG-di(photolabile acrylate) (PEG-DPA) has been  consistently used as a building block in these hydrogels50. Upon ultra violet (UV) light exposure, ester groups linked to ortho-nitrobenzyl  photolabile groups cleave into acetal and acidic moieties, promoting  siRNA release. Photolabile hydrogels have been also prepared using  Michael addition to control the release of siRNA-PEI nanocomplexes80.  The photodegradable hydrogels with the lowest amount of photola bile moieties showed an increase in the hydrolytic degradation rate  of ester bonds, which enhances siRNA therapeutics release。  

---

 ## 翻译[23/77]：
 

### 光敏水凝胶的构成

通常，这些水凝胶包含单个或多个光可降解基团（例如，带有酯或酰胺键的硝基苯基连接剂），其在光波长和强度以及照射时间下具有不同的降解特性。RNA通过可光解键连接到水凝胶网络上，而RNA纳米递送体则通过这些光敏键与交联的水凝胶一起封装。在这些水凝胶中，常常使用可光降解的PEG-di(光敏丙烯酸酯) (PEG-DPA) 作为基础构件。在紫外（UV）光照射下，连接到邻硝基苯光敏基团的酯基断裂成乙缩醛和酸性基团，促进siRNA释放。还可以使用迈克尔加成法制备可光降解的水凝胶，以控制siRNA-PEI纳米复合物的释放。具有最低量光敏基团的可光降解水凝胶显示出酯键的水解降解速率增加，从而增强了siRNA的治疗释放。



## 

---

 ## 原文[24/77]： 

  In addi tion, the siRNA profile release from photolabile hydrogels was also  affected by UV light exposure. Remarkably, the selective delivery of  miRNA was achieved by using PEG-based hydrogels via a copper-free  click reaction and conjugated with UV-cleavable Chol-miR-26a, which  allows control over miRNA release by tailoring UV irradiation time and UV intensity.

 Altogether, proper design of hydrogels with photo-degradable  linkers can achieve on-demand release of RNA therapeutics upon  UV radiation. However, due to the low penetration of UV light, these  hydrogels may not be suitable for use in deep tissues. 

Nature Materials | Volume 22 | July 2023 | 818–831 824

 biomedical applications (Table 2). Hydrogels are primarily used to facili tate local administration of RNA therapeutics to the disease site and to  protect the RNA from innate immune responses. However, depending  on the disease pathology, hydrogels can be modified to yield various  release profiles to maximize the efficacy of RNA therapeutics。  

---

 ## 翻译[24/77]：
 

 生物医学应用（表2）此外，UV光照也会影响从可光降解水凝胶中释放的siRNA配置文件。值得注意的是，通过使用PEG基水凝胶通过无铜点击反应与UV可裂解的Chol-miR-26a共轭，实现了miRNA的选择性传递，这允许通过调整UV照射时间和UV强度来控制miRNA的释放。



总而言之，通过合理设计具有可光降解连接剂的水凝胶，可以实现RNA治疗物的按需释放，以响应UV辐射。然而，由于UV光的穿透能力较低，这些水凝胶可能不适用于深层组织的使用。



《自然材料》 | 2023年7月 | 第22卷 | 818-831页



生物医学应用（表2）主要用于促进RNA治疗物在疾病部位的局部给药，并保护RNA免受先天免疫反应。然而，根据疾病病理学的不同，可以改变水凝胶的性质以实现各种释放配置文件，以最大限度地提高RNA治疗物的功效。



## 

---

 ## 原文[25/77]： 

  Below,  we primarily highlight the use of RNA delivery hydrogels in cancer  therapy, bone regeneration, cardiac repair and wound healing (Fig. 6).

 Systemic cancer treatment is useful for metastasis but is also associated  with systemic toxicity and possible immunogenicity due to leakage/ accumulation in major organs. In this context, hydrogels could facilitate  long-term and sustained local delivery of RNA therapeutics to reduce  potential side effects while attacking the primary tumour24,67, repro gramming the primary tumour to prevent metastasis81 and/or inhibit ing the recurrence of the primary tumour after surgical resection68. 

 Accordingly, different types of activated oncogene mRNA or miRNA can  be effectively inhibited by RNAi technology to inhibit tumour growth.  For example, NPs containing RNA therapeutics (for example, miRNA)  can be embedded in a hydrogel matrix, which is in turn implanted next  to the tumour24,81。  

---

 ## 翻译[25/77]：
 

 RNA递送水凝胶在癌症治疗中的应用下面，我们主要介绍了RNA递送水凝胶在癌症治疗、骨再生、心脏修复和伤口愈合方面的应用（图6）。



 在癌症系统治疗方面，虽然有助于抑制转移，但也存在系统毒性和由于泄露/在主要器官积累而可能产生免疫原性的问题。在这种情况下，水凝胶可以促进RNA治疗剂的长期持续局部递送，以减少潜在的副作用，同时攻击原发肿瘤24,67，重新编程原发肿瘤以防止转移81，以及/或在手术切除后抑制原发肿瘤的复发68。

 因此，不同类型的激活型癌基因mRNA或miRNA可以通过RNAi技术得以有效抑制肿瘤生长。例如，含有RNA治疗剂（例如miRNA）的纳米颗粒可以嵌入在水凝胶基质中，然后植入到肿瘤旁边24,81。

## 

---

 ## 原文[26/77]： 

  Remarkably, a hydrogel network composed of a  two-component system, namely Schiff-base interactions between an  oxidized polysaccharide and an amine-containing dendrimer, demon strated the use of the ratio of aldehyde to amine groups to control the 

 release rate of RNA therapeutics. However, highly crosslinked hydro gels can hinder the release of embedded RNA therapeutics, reducing  therapeutic efficacy. To address this issue, one-component injectable  polyplex hydrogels were used to deliver RNA therapeutics (for example, 

 siRNA) with higher efficiency19,21. Typically, these polyplex systems  contain a thermo-sensitive moiety that allows sol-to-gel transition  upon injection into the target tissue. Subsequently, the release rate of  RNA-containing polyplexes from these gels depends on their dissolu tion rate, which can be further controlled by incorporating degradable  linkers sensitive to hydrolysis or enzymatic activity. Consequently,  hydrogel-mediated delivery of RNA therapeutics for cancer therapy  entails prolonged retention of the nano-vectors around the tumour,  which enhances uptake by the particular cancer cell population。  

---

 ## 翻译[26/77]：
 

 释放RNA治疗物的方法

非常引人注目的是，由含有氧化多糖和胺基树枝状分子之间的Schiff碱基作用构成的两组分水凝胶网络，证明了醛基与胺基的比例可控制RNA治疗物的释放速率。然而，高度交联的水凝胶可以阻碍嵌入的RNA治疗物的释放，降低治疗效果。为了解决这个问题，使用一组分可注射聚合物复合物水凝胶来传递RNA治疗物（例如siRNA）具有更高的效率。通常，这些复合物系统含有热敏性部分，使其在注射到目标组织时能发生溶胶-凝胶转变。随后，这些胶体中含有RNA的聚合物复合物的释放速率取决于其溶解速率，而这可以通过引入对水解或酶活性敏感的可降解链接剂进一步控制。因此，水凝胶介导的RNA治疗物传递用于癌症治疗需要在肿瘤周围延长纳米载体的保留时间，从而增强特定癌细胞群体的摄取。



## 

---

 ## 原文[27/77]： 

  This  becomes crucial when dealing with brain tumours, as such platforms  are capable of overcoming biological barriers (mainly the blood–brain  barrier) to deliver therapeutics to the brain tissue. In general, hydro gels for the delivery of RNA therapeutics in cancer have demonstrated  enhanced bioavailability and increased tumour accumulation with less  homing in non-target tissues. In the context of cancer, RNA hydrogel  delivery is not limited to silencing of oncogenic genes, and the next  great achievement on the horizon could be manipulation of immu nomodulatory factors to recruit immune cells for cancer immuno-therapy82.

 Bone regeneration and repair is another arena in which hydrogel  mediated RNA delivery has shown promise72,75. Bone healing relies on  several dynamic and spatiotemporal mechanisms, including inflam matory, repair, and remodeling phases at crucial cellular (that is,  inflammatory cells, vascular cells, osteochondral progenitors, and 

 growth factors, and angiogenic and pro-osteogenic factors)83。  

---

 ## 翻译[27/77]：
 

 脑肿瘤中的RNA递送平台

当处理脑肿瘤时，这变得尤为重要，因为这样的平台能够克服生物屏障（主要是血脑屏障），将治疗药物递送到脑组织。在癌症中，用于RNA治疗递送的水凝胶已经展示出增强的生物利用度和肿瘤在非靶组织中的积累较少的现象。在癌症中，RNA水凝胶递送并不局限于沉默致癌基因，下一个重要成就可能是通过调节免疫调控因子来招募免疫细胞进行癌症免疫治疗。



 骨再生和修复中的RNA递送

骨再生和修复是另一个RNA递送的领域，已经显示出希望。骨愈合依赖于几个动态的和时空的机制，包括关键细胞（即炎症细胞、血管细胞、骨软骨祖细胞和生长因子、血管生成和促骨生成因子）的炎症、修复和重塑阶段。



## 

---

 ## 原文[28/77]： 

  As a  result, it is crucial for the hydrogels to modulate the spatio-temporal  and dose-controlled release of RNA therapeutics to meet the highly  complex microenvironment present during bone regeneration. Cor respondingly, if the hydrogels are to be implemented as a scaffold,  their degradation should correlate with the rate of ingrowing tissue  to provide sufficient mechanical support. Given such requirements,  photodegradable hydrogels have shown immense potential to facilitate 

 the on-demand release of RNA therapeutics80. In these systems, the  hydrogels contain both hydrolytically degradable linkages (for exam ple, disulfide and/or ester bonds) as well as photolytically degradable  sites (thiol-acrylate bonds). Therefore, UV radiation induces photodeg radation of photolabile linkages in the hydrogel network, affecting the  hydrogel’s physiochemical properties such as swelling and degradation  rate. The results showed that UV radiation can lead to faster release of  siRNA from these hydrogels, and that the associated release rate can  be further modified by adjusting the ratio of photolabile groups in the  hydrogel composition。  

---

 ## 翻译[28/77]：
 

 空间和时间控制的RNA治疗物的释放因此，对于水凝胶来说，调节RNA治疗物的空间和时间上的剂量控制释放以满足骨再生过程中高度复杂的微环境非常关键。如果这些水凝胶被用作支架，则它们的降解速度应与新生组织的生长速度相一致，以提供足够的机械支持。考虑到这些要求，光降解水凝胶已显示出巨大的潜力来促进RNA治疗物的按需释放80。在这些系统中，水凝胶含有可水解降解的连接（例如二硫键和/或酯键）以及可光解降解的位点（巯基-丙烯酸酯键）。因此，紫外辐射诱导水凝胶网络中光敏不稳定结合物的光降解，影响水凝胶的物理化学性质，如肿胀和降解速率。结果表明，紫外辐射可以导致siRNA从这些水凝胶中更快地释放，并且相关的释放速率可以通过调整水凝胶组成中光敏不稳定基团的比例进一步改变。



## 

---

 ## 原文[29/77]： 

  Hydrogels of this sort allow temporal tuning  of RNAi presentation directly at the diseased site, which is known to  enhance bone formation84. Although research studies have explored  the delivery of osteogenesis-inducing therapeutic agents, it is also  possible to study additional cell responses, including angiogenesis and cell infiltration.

 Table 2 | Biomedical applications of hydrogel-based RNA delivery Nature Materials | Volume 22 | July 2023 | 818–831 826

 MI results from coronary artery occlusion, producing local ischemia,  tissue damage, and ultimately, heart failure. There are interesting  approaches that have been applied to enhance ECM homeostasis and  angiogenesis or to prevent fibrosis and calcium imbalance, namely  the delivery of siRNA, miRNA and short hairpin RNA (shRNA)85.  Remarkably, the use of self-healing hydrogels that are injected into  the infarct site using minimally invasive approaches (for example,  catheters) and are able to reform after this shear cessation has been  a promising option to the challenge of delivery and retention of  RNAi therapeutics86。  

---

 ## 翻译[29/77]：
 

 纳米凝胶在RNAi递送中的应用这种类型的纳米凝胶可以在疾病部位直接实现RNAi递送的时间调控，已知这种方法可以增强骨形成84。尽管研究已经探索了诱导骨生成的治疗方法的递送，但也可以研究其他细胞反应，包括血管生成和细胞浸润。



 表2 | 基于纳米凝胶的RNA递送的生物医学应用《自然材料》 | 第22卷 | 2023年7月 | 818-831 | 826



 心肌梗死中的RNA递送心肌梗死(MI)是冠状动脉阻塞造成的局部缺血、组织损伤以及最终心力衰竭的结果。有一些有趣的方法已经应用于增强细胞外基质(ECM)的稳态和血管生成，或者预防纤维化和钙平衡失调，包括siRNA、miRNA和短发夹RNA(shRNA)的递送85。值得注意的是，使用自愈合纳米凝胶通过微创途径（例如导管）注射到梗死部位，并在这种剪切停止后能够重新形成，已成为RNAi治疗的递送和保留的有前景的选择86。



## 

---

 ## 原文[30/77]： 

  To this end, a variety of chemistries, including  ionic bonds87 and dynamic covalent bonds (hydrazone linkages25  and guest–host interactions40), have been implemented to yield  injectable self-healing hydrogels for RNAi delivery. Among them, 

 guest–host hydrogels (involving CD molecules) can facilitate a slower  release of cholesterol-modified RNAi via hydrophobic interactions.  Stimuli-responsive linkages (for example, protease-sensitive78  and pH-responsive76) were also utilized as other means to achieve  on-demand release from injectable self-healing hydrogels. Particu larly, these two stimuli were chosen because MI is associated with  changes in the tissue microenvironment, including a reduction in  pH (from 7.4 to 6.8) and local upregulation of proteolytic activity.  This emphasizes the importance of considering disease pathology  when designing hydrogels for RNA delivery。  

---

 ## 翻译[30/77]：
 

 不同类型的化学反应被用于制备可注射的自修复水凝胶用于RNAi传递。这些反应包括离子键和动态共价键（如酰肼键和宿主-客体相互作用）。其中，宿主-客体水凝胶（包含环糊精分子）通过疏水作用可以促进胆固醇修饰的RNAi缓慢释放。另外，也利用了刺激响应链（如蛋白酶敏感链和pH响应链），实现了从可注射的自修复水凝胶中按需释放。特别地，选择了这两种刺激因为MI（心肌梗死）与组织微环境的变化有关，其中包括pH的降低（从7.4到6.8）和局部蛋白酶活性的上调。这突出了在设计RNA传递的水凝胶时需要考虑疾病病理学的重要性。

## 

---

 ## 原文[31/77]： 

  In general, a significant  advantage of RNAi delivery using injectable self-healing hydrogels is  that single-dose administration of such systems can significantly and  continuously restore the infarcted myocardium and enhance cardiac  function over an extended period (from one to three months). Given  the role of the immune response in MI disease progression and repair,  hydrogels can play an essential role in delivering RNA therapeutics  for manipulation of macrophages and regulatory T cells, limiting  pro-inflammatory responses and increasing regenerative cytokines in the infarct region.

 Wound healing is a well orchestrated and regulated process that can be  divided into three overlapping phases: haemostasis and inflammation,  proliferation, and tissue remodeling88. However, this process becomes  severely dysregulated by pathophysiological conditions. RNAi thera peutics have already shown potential in addressing all three phases  and therefore facilitating functional tissue regeneration. Hydrogels  can play a central role in both the local delivery of RNAi therapeutics  and providing an artificial matrix to aid in the healing process。  

---

 ## 翻译[31/77]：
 

 RNAi递送使用可注射的自愈合水凝胶的显著优势在于单剂量的应用可以显著并持续地修复梗死心肌，增强心脏功能在一个较长的时间段内（从一个到三个月之间）。鉴于免疫反应在心肌梗死病程进展和修复中的作用，水凝胶可以在RNA治疗递送方面发挥关键作用，用于操控巨噬细胞和调节性T细胞，限制炎症反应并增加再生因子在梗死区域。

 创伤修复是一个精密协调和调控的过程，可以分为三个相互重叠的阶段：止血和炎症、增殖和组织重塑。然而，这一过程在病理生理条件下会严重失调。RNAi治疗已经显示出在处理这三个阶段并促进功能性组织再生方面的潜力。水凝胶可以在局部RNAi治疗的递送和提供人造基质促进修复过程中发挥核心作用。

## 

---

 ## 原文[32/77]： 

  For  instance, thermo-responsive hydrogels (for example, pluronic F-127,  methylcellulose and agarose) have commonly been used to deliver  miRNA or siRNA to accelerate wound healing89. One disadvantage of  such hydrogels may be the inability to control the release rate of the encapsulated RNAi therapeutics.

 To address this issue, both physically and chemically crosslinked  hydrogels have been employed, and the degree of crosslinking was  used to control the release rate of RNAi therapeutics. A common exam ple of physically crosslinked hydrogels is the layer-by-layer assembly  of two oppositely charged biopolymers90. Increasing the number of  layers led to a slow release of RNAi therapeutics from these hydrogels.  Given their physical nature, these gels are capable of releasing RNAi  over a span of 2 weeks. For chemically crosslinked hydrogels, other  variables can also affect the release rate of RNAi therapeutics. This  generally depends on the entities involved in forming the chemical  crosslinks within the hydrogel。  

---

 ## 翻译[32/77]：
 

 热响应性水凝胶在加速伤口愈合中递送miRNA或siRNA的研究例如，热响应性水凝胶（如聚氧乙烯-聚丙烯醚F-127、甲基纤维素和琼脂）广泛用于递送miRNA或siRNA以加速伤口愈合^89^。这类水凝胶的一个缺点可能是无法控制包封RNAi疗法的释放速率。



为了解决这个问题，研究人员采用了物理交联和化学交联两种水凝胶，并利用交联程度来控制RNAi疗法的释放速率。物理交联水凝胶的常见例子是两种带电生物聚合物的层层组装^90^。增加层数会导致这些水凝胶中RNAi疗法的缓慢释放。由于其物理特性，这些凝胶能够在2周内释放RNAi。对于化学交联水凝胶，其他变量也可以影响RNAi疗法的释放速率。这通常取决于在水凝胶中形成化学交联的物质。



## 

---

 ## 原文[33/77]： 

  For instance, the crosslinking could  be a result of Schiff base bonds between aldehyde and amine groups  Nature Materials | Volume 22 | July 2023 | 818–831 827

 on polymer matrixes91. These hydrogels often degrade slowly over  a period of a month, and hence they yield a longer release profile  for RNAi therapeutics. Conversely, hydrogels formed as a result of  interactions between the polymer matrix and the RNAi nano-vector  are degraded more quickly (maximum, seven days), yielding a shorter  release profile92,93. In these cases, there is a direct correlation between  the number of active functional groups on the nano-vector and the  corresponding hydrogel crosslinking density. As a result, the release  rate of encapsulated RNAi can be simply tuned by adjusting the con centration of nanocarrier in the hydrogel. Notably, nanocarriers with  active surface functionalities can be incorporated into chemically  crosslinked hydrogel networks as a way to provide more control over  the release rate of RNAi therapeutics28. The miRNA-laden hydrogels  drive wound healing by triggering resolution of the inflammatory  phase。  

---

 ## 翻译[33/77]：
 

 聚合物基质上的交联作用

例如，交联作用可能是醛和胺基团之间的Schiff碱键的结果。在这些水凝胶中，其降解速度通常较慢，需要一个月的时间，因此可实现更长时间的RNAi治疗药物释放效应。相反，由聚合物基质和RNAi纳米载体之间的相互作用形成的水凝胶会更快地被降解（最长可达七天），从而实现更短的释放效应。在这些情况下，纳米载体表面上活性功能团数量与相应水凝胶的交联密度之间存在直接相关性。因此，通过调整水凝胶中纳米载体的浓度，可以简单地调节封装的RNAi的释放速率。值得注意的是，具有活性表面功能的纳米载体可以被纳入到化学交联的水凝胶网络中，以更好地控制RNAi治疗药物的释放速率。miRNA载体的水凝胶通过触发炎症阶段的解决来促进伤口愈合。



## 

---

 ## 原文[34/77]： 

  The results showed elevated macrophage infiltration and effec tive local polarization of macrophages toward the M2 phenotype  in vivo. Hydrogels, with their remarkably high water uptake, support  cell attachment and growth, leading to better wound healing. These  hydrogel examples yield a spectrum of different temporal release  profiles for RNAi therapeutics, which is particularly beneficial when  considering that wound healing consists of a carefully orchestrated sequence of biological events.

 Notably, the risk of infection or localized trauma is commonly  associated with the use of conventional methods for wound closure  (for example, sutures). Therefore, the use of hydrogel-based adhesives,  which strongly attach to the wound, can be used as a physical barrier to  protect the wound from the above-mentioned risks that will strongly affect re-epithelialization and healing rate94.

 RNA molecules have received a great deal of attention for immu nomodulation, mainly due to RNA silencing of crucial factors  in immune cells95. Adhesive hydrogels have been used as immu nomodulatory dressings。  

---

 ## 翻译[34/77]：
 

 结果显示，在体内观察到了巨噬细胞浸润的增加，并且巨噬细胞向M2表型的局部极化表现出有效性。水凝胶具有极高的吸水性，能够支持细胞附着和生长，从而促进更好的伤口愈合。这些水凝胶的例子展现了不同时间释放RNAi治疗药物的各种谱系，这在考虑到伤口愈合是由一系列精心协调的生物事件组成时，尤其有益。

值得注意的是，传统的伤口闭合方法（如缝合）常与感染或局部创伤的风险相关。因此，使用水凝胶黏合剂作为物理障碍，强力贴附到伤口上，可以作为保护伤口免受上述风险影响的屏障，从而有效影响再上皮化和愈合速度。



 RNA分子由于对免疫细胞中关键因子的RNA沉默作用，而受到了免疫调节的广泛关注。黏附性水凝胶已被用作免疫调节敷料。

## 

---

 ## 原文[35/77]： 

  For the combined delivery of dendritic  cell (DC) chemo-attractants (MIP3a) and pDNA-siRNA-loaded micro-

 particles to antigen-presenting cells, an in situ crosslinkable and  fast-degrading hydrogel was developed96. DCs were able to infiltrate  the hydrogels and efficiently phagocytose the microparticles carry ing pDNA-siRNA. The gels attracted four to sixfold more DCs com pared with an equivalent bolus dose. A more recent study showed  that, upon the in vivo delivery of mRNA–lipoplexes loaded into  chitosan–alginate hydrogel, T-cell proliferation and interferon-γ  secretion were both increased60. At week 1, a humoral response was  observed for lipoplex-loaded hydrogels, while protein-based vac cines did not elicit IgG production until 2 weeks post-injection, which 

 potentiated their applications as a viable immunization method against multiple diseases.

 The process of angiogenesis is closely tied to wound healing and  tissue regeneration。  

---

 ## 翻译[35/77]：
 

 植入扩散素（MIP3a）和pDNA-siRNA负载微粒的树突状细胞（DC）化学引诱剂的共同传递，发展了一种原位可交联和快速降解的水凝胶[96]。 DC能够渗透水凝胶并高效吞噬携带pDNA-siRNA的微粒。与等效剂量的一次性给药相比，凝胶吸引了4至6倍更多的DC。最近的研究表明，在将负载了mRNA-lipoplexes的壳聚糖-海藻酸盐水凝胶体内输送时，T细胞增殖和干扰素-γ分泌均增加了[60]。在第1周，脂质体负载的水凝胶观察到了体液免疫反应，而基于蛋白的疫苗直到注射后2周才引起IgG的产生，这增强了它们作为一种可行的用于多种疾病免疫方法的应用。

血管生成过程与创伤愈合和组织再生密切相关。



## 

---

 ## 原文[36/77]： 

  Stimulating both the formation and maturation  of blood vessels is therefore of great interest, especially in the treat ment of some chronic skin wounds. Localized silencing of ubiquitously  expressed genes (for example, mapk-1) in an open wound bed was dem onstrated using an agarose hydrogel loaded with liposomal siRNA97.  Delivery of siRNA NPs via hydrogels incorporating polyurethane  (PUR) and its derivatives, polyester urethane (PEUR) or poly(thioketal  urethane) (PTK-UR), was also explored for angiogenesis98. Modulat ing the release rate caused changes in the in vivo silencing profile.  Silencing prolyl hydroxylase domain protein 2 (PHD2) resulted in  the expression of vascular endothelial growth factor and fibroblast  growth factor, while vascular volume and thickness within the hydro gels also increased. The use of these hydrogels for local PHD2 siRNA  delivery showed excellent promise for promoting angiogenesis for  wound healing.

 Some other reported applications, such as spinal cord injury,  fibrosis and inflammatory diseases, are summarized in Table 2.
  

---

 ## 翻译[36/77]：
 

 刺激血管形成和成熟在治疗一些慢性皮肤创伤中非常重要。

因此，通过使用装载了脂质体siRNA的琼脂糖水凝胶，在开放性伤口部位局部沉默广泛表达的基因（例如mapk-1）已经得到了证明。



探索了通过聚氨酯（PUR）及其衍生物聚酯型聚氨酯（PEUR）或聚（硫酮糖酰基）聚氨酯（PTK-UR）封装siRNA NPs的水凝胶用于促进血管生成的方法。



改变释放速率会引起体内沉默的改变。沉默脯氨酸羟化酶结构域蛋白2（PHD2）会导致血管内皮生长因子和成纤维细胞生长因子的表达增加，同时水凝胶内的血管容积和厚度也增加。



将这些水凝胶用于局部传递PHD2 siRNA在促进创伤愈合中展现出了卓越的应用前景。



已在表2中总结了其他报道的应用，如脊髓损伤、纤维化和炎症性疾病。



## 

---

 ## 原文[37/77]： 

  Macroscale delivery systems that can be locally implanted on the dis ease tissue while avoiding the complications associated to the systemic  delivery of RNA therapeutics, have captured the attention of research ers in the field in the past decades. Particularly, hydrogels can be used  to efficiently deliver both small and macro molecules, like chemo therapeutics, proteins and genetic materials (such as RNA), along with  nanoparticle-based therapies. Hydrogels as a three-dimensional matrix  framework have gained attention in therapeutics due to their biocom patibility, biodegradability, drug loading ability and controlled drug  release. Compared with systemic administration, hydrogel systems  have many advantages, such as locally controlled RNA delivery, low  blood RNA concentration, high permeability, few toxic side effects,  avoidance of first-pass hepatic metabolism, and minimal pain and  discomfort70,75. The combination of a local platform to treat and  re-educate the disease tissue along with systemic administration to  treat an existing distant disease niche would impart highly efficacious  translational therapeutic platforms with improved clinical outcomes81.  To take this to the next level, macroscale hydrogels have recently been  developed with nano/micro hydrogel building blocks99。  

---

 ## 翻译[37/77]：
 

### 大范围交付系统



在过去的几十年中，能够在患病组织上局部植入而避免与系统性RNA治疗相关的并发症的宏观交付系统，已经引起了该领域研究人员的关注。特别是，水凝胶可以用于有效地输送小分子和宏观分子，如化疗药物、蛋白质和遗传材料（如RNA），以及基于纳米颗粒的治疗。作为三维结构框架的水凝胶因其生物相容性、可降解性、药物负载能力和控制释放能力而备受关注。与全身给药相比，水凝胶系统具有许多优点，例如局部控制的RNA输送，低血液RNA浓度，高渗透性，毒性副作用少，避免了首过肝代谢，最小化疼痛和不适感。通过结合局部平台来治疗和重新教育疾病组织以及通过全身给药来治疗现有的远处病灶，可以产生具有改善临床效果的高效转化治疗平台。为了将这一技术提升到一个新的水平，最近已经研发出了具有纳米/微米水凝胶构件的大范围水凝胶。



## 

---

 ## 原文[38/77]： 

  Hydrolytic  degradation of macroscale hydrogels then allowed for the gradual  release of RNA-loaded nano/micro hydrogels without leaving any  residual biomaterial at the disease site after treatment. The balance  between hydrogel-RNA design complexity, manufacturing costs, regu latory policies and the effective release into the target tissue needs to  be evaluated in detail so these strategies can be commonly applied in  clinical procedures.

 Disease location and targeted tissue will dictate the necessary  physical attributes of the hydrogel while disease type will determine  the suitable spatiotemporal RNA release profile. Injectable hydrogels  with self-healing properties are extremely useful for heart delivery,  while topical hydrogels with adhesive properties are preferred for  RNA delivery to the skin. For instance, self-healing hydrogels can with stand the shear forces during injection as well as the dynamic forces  generated by the beating muscles after myocardium injection. Fur ther parameters must be taken into consideration when hydrogels  are also intended to serve as a scaffolding matrix to promote tissue  regeneration. This includes parameters such as mechanical robust ness and degradation rate of the hydrogels, which can inevitably affect  the release rate of encapsulated RNA therapeutics。  

---

 ## 翻译[38/77]：
 

### 水解降解

以宏观尺度水凝胶的水解降解最终实现了RNA加载的纳/微水凝胶在治疗后不留下任何残留生物材料。需要详细评估水凝胶-RNA设计复杂性、制造成本、规章政策以及有效释放到目标组织中的平衡，以便这些策略可以常规应用于临床操作。



 疾病位置和靶向组织疾病位置和靶向组织将决定水凝胶所需的物理属性，而疾病类型将决定合适的时空RNA释放模式。具有自修复特性的可注射水凝胶在心脏输送方面非常有用，而具有粘附特性的局部应用水凝胶更适用于皮肤RNA输送。例如，自修复水凝胶可以经受注射过程中的剪切力以及心肌注射后由肌肉搏动产生的动力力。如果水凝胶还打算作为支架基质促进组织再生，还必须考虑其他参数。这些参数包括水凝胶的力学强度和降解速率，这些不可避免地会影响封装的RNA治疗物的释放速率。



## 

---

 ## 原文[39/77]： 

  For example, RNA  delivery to injured bone tissue must be commensurate with the healing  timeline (approximately 3–4 weeks)33. Hence, depending on the type  of RNA and its association with a specific healing phase, the delivery  timeline could vary from several days to several months100. Addition ally, disease-associated changes to a tissue microenvironment, such as  altered pH or upregulation of certain enzymes, can be implemented in the hydrogel design to trigger RNA release.

 As mentioned above, biomedical applications of hydrogel  mediated RNA delivery can range from tissue regeneration to cancer  therapy. However, one unexplored area is the employment of hydrogel  scaffolds to support RNA–cell interactions. Here, hydrogels function  as a staging area for gene regulation and engineering as cells migrate  into the hydrogels for interaction with RNAs. This concept has been uti lized in incorporating previously gene-modified human mesenchymal  stromal cells into a cryogel scaffold101. These genetically modified cells  can release certain antibodies capable of triggering T-cell-mediated  anti-tumour responses。  

---

 ## 翻译[39/77]：
 

 RNA传递与骨骼损伤愈合时间相协调  例如，RNA传递到受伤的骨骼组织必须与愈合时间相一致（大约3-4周）33。因此，根据RNA的类型以及其与特定愈合阶段的关联情况，传递时间可能从几天到几个月不等100。此外，组织微环境的疾病相关变化，如pH值的改变或某些酶的上调，可以在水凝胶设计中应用以触发RNA释放。



 水凝胶支持RNA-细胞相互作用如上所述，水凝胶介导的RNA传递的生物医学应用范围可以从组织再生到癌症治疗。然而，一个未被探索的领域是利用水凝胶支架支持RNA-细胞相互作用。在这里，水凝胶充当基因调控和工程的舞台，细胞迁入水凝胶与RNA进行交互作用。这个概念已经被用于将先前基因修饰的人间充质干细胞纳入到冷冻凝胶支架中101。这些基因修饰细胞可以释放出触发T细胞介导的抗肿瘤反应的特定抗体。



## 

---

 ## 原文[40/77]： 

  Ultimately, hydrogel scaffolds for RNA-cell  interactions could have a combinatorial effect by simultaneously edit ing certain genes in the cells and supporting their proliferation and  survival, ensuring the constant release of effective levels of antibodies. Another promising application of hydrogels in this field is the  delivery of RNA nano-vaccines. The coronavirus disease 2019 (COVID 19) pandemic is still raging all over the world, and vaccination is the  best defence. After unremitting efforts, two mRNA vaccines based on  lipid NPs (BNT162b2 by Pfizer/BioNTech and mRNA-1273 by Moderna)  

Nature Materials | Volume 22 | July 2023 | 818–831 828

 are now in clinical use. Injectable hydrogels were recently used for  local delivery of severe acute respiratory syndrome coronavirus 2  (SARS-CoV-2) polymeric nano-vaccines (containing the SARS-CoV-2  virus spike protein with/without adjuvant) in animal models102。  

---

 ## 翻译[40/77]：
 

 RNA-细胞相互作用中的水凝胶支架水凝胶支架可以通过同时编辑细胞中的特定基因、支持细胞的增殖和存活，以确保持续释放有效水平的抗体，从而在RNA-细胞相互作用中产生组合效应。水凝胶在这一领域的另一个有前景的应用是RNA纳米疫苗的传递。



 水凝胶在RNA纳米疫苗传递中的应用2019冠状病毒病（COVID-19）疫情仍在全球肆虐，疫苗是最好的防御措施。经过不懈努力，两种基于脂质纳米粒子的mRNA疫苗（Pfizer/BioNTech的BNT162b2和Moderna的mRNA-1273）已经开始临床应用。最近，可注射的水凝胶被用于动物模型中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）聚合物纳米疫苗（含有SARS-CoV-2病毒刺突蛋白，有/无辅助剂）的局部传递。



## 

---

 ## 原文[41/77]： 

  Interest ingly, the results show that sustained delivery of the receptor-binding  domain (RBD) of the SARS-CoV-2 spike protein nano-vaccine in an  injectable hydrogel depot formulation achieved higher total anti-RBD  IgG titres compared to bolus vaccine controls. A similar concept can  be applied to current SARS-CoV-2 mRNA vaccines by incorporating  them into hydrogels. Currently, these mRNA nano-vaccines require  two doses separated by 3-4 weeks. The use of hydrogel capsules with  pulsatile release could release the vaccines in pulses over weeks 3–4,  which if injected along with free nano-vaccines, might provide one-shot  vaccination103. However, it should also be noted that little has been  done to examine the in vivo stability of mRNA in hydrogels at physi ological conditions for such a long period of time, which will be an  important area for future studies. Indeed, for larger RNAs such as  mRNA, suboptimal stability elicits only short-term transient protein  expression and requires delivery vehicles like NPs to protect them from  enzymatic degradation and improve their transfection efficiency。  

---

 ## 翻译[41/77]：
 

 有趣的是，结果显示，通过注射性水凝胶混悬剂制剂实现对SARS-CoV-2螺旋状蛋白受体结合结构域（RBD）纳米疫苗的持续释放，与脉冲疫苗对照相比，抗-RBD总IgG滴度更高。目前，这个类似的概念可以用于将当前的SARS-CoV-2 mRNA疫苗纳入水凝胶中。目前，这些mRNA纳米疫苗需要间隔3-4周接种两剂。采用具有脉冲释放特性的水凝胶胶囊可以在第3-4周内脉冲释放疫苗，如果和自由纳米疫苗一起注射，可能实现一次接种。然而，也应该注意的是，至今没有对mRNA在生理条件下长时间存储于水凝胶中的体内稳定性进行充分的研究，这将是未来研究的一个重要领域。事实上，对于像mRNA这样的较大RNA，亚最适稳定性只会产生短期的瞬时蛋白表达，并需要纳米颗粒等输送载体来保护它们免受酶解和提高转染效率的影响。

## 

---

 ## 原文[42/77]： 

  The  use of hydrogels for naked mRNA delivery has rarely been reported.  Thus, for future efforts to modify large RNAs to improve stability and  transfection, the application of hydrogels for naked RNA delivery will  be more fruitful. Another issue with mRNA nano-vaccines is that they  must be stored and shipped at low temperatures. Given the current  scant evidence, identifying hydrogels suitable for long-term mRNA  storage at 4 °C or even room temperature will be important. With fur ther research, hydrogel-mediated mRNA vaccine delivery may become  a viable alternative to traditional nucleic acid immunization methods. In this Review, we have discussed the use of hydrogels as RNA  delivery systems from design to biomedical applications. The research  discussed herein demonstrates that hydrogel systems are capable  not only of sustained local delivery of RNA (which avoids repeated  administration) but also of spatial and temporal control over release  rate. Further investigation in vivo of the characteristics of RNA-loaded  hydrogels, such as degradability, clearance, controlled release and  foreign body response, is urgently needed。  

---

 ## 翻译[42/77]：
 

 水凝胶在裸的mRNA传递方面的使用鲜有报道水凝胶在裸的mRNA传递方面的应用极少报道。因此，对于未来改进大分子RNA的稳定性和转染的研究，使用水凝胶作为裸的RNA传递方式将更有成果。另外，mRNA 纳米疫苗的另一个问题是必须低温储存和运输。鉴于当前证据匮乏，寻找适合长时间在4℃ 或者室温下储存mRNA的水凝胶将非常重要。通过进一步的研究，水凝胶介导的mRNA疫苗传递可能成为传统核酸免疫方法的可行替代品。本综述中，我们讨论了水凝胶作为RNA传递系统的设计到生物医学应用的使用。所讨论的研究表明，水凝胶系统不仅能持续局部传递RNA（避免了重复给药），还能对释放速率进行时空控制。急需进一步研究RNA加载水凝胶在体内的特性，如可降解性、清除性、控制释放和异物反应。



## 

---

 ## 原文[43/77]： 

  It is expected that continu ous improvements in hydrogel design and fabrication will bring these  exciting materials ever closer to clinical applications of RNA therapy.

 References 

1.  Yin, H. et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541–555 (2014).

 2.  Wu, S. Y., Lopez-Berestein, G., Calin, G. A. & Sood, A. K. RNAi  therapies: drugging the undruggable. Sci. Transl. Med. 6,  240ps7 (2014).

 3.  Mendes, B. B. et al. Nanodelivery of nucleic acids. Nat. Rev. Methods Primers 2, 24 (2022).
  

---

 ## 翻译[43/77]：
 

 预期哈德罗凝胶设计和制备的持续改进将使得这些令人兴奋的材料更接近RNA治疗的临床应用。

# 参考文献



1. Yin, H.等。基因治疗的非病毒载体。《自然基因评论》，15(2014), 541-555。



2. Wu, S. Y.，Lopez-Berestein, G.，Calin, G. A.和Sood, A. K. RNAi疗法：对难以靶向的基因进行药物靶向。《科学转化医学》，6(2014), 240ps7。



3. Mendes, B. B.等。核酸的纳米递送。《自然方法前沿》，2(2022), 24。



## 

---

 ## 原文[44/77]： 

  4.  Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics— developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).

 5.  Davidson, B. L. & McCray, P. B. Current prospects for   RNA interference-based therapies. Nat. Rev. Genet. 12,  329–340 (2011).

 6.  Peng, Y. & Croce, C. M. The role of microRNAs in human cancer.  Signal Transduct. Target Ther. 1, 15004 (2016). 7.  Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery  systems for RNA therapeutics. Nat. Rev. Genet。  

---

 ## 翻译[44/77]：
 

 Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics— developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).Sahin等人指出，mRNA基因治疗正发展为一种新型药物。Nat. Rev. Drug Discov.期刊中的研究发现，mRNA基因治疗具有广阔的应用前景。

 

 Davidson, B. L. & McCray, P. B. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 12, 329–340 (2011).Davidson和McCray综述了RNA干扰治疗的当前前景。该综述发表在Nat. Rev. Genet.期刊上，强调了RNA干扰治疗的潜力。



 Peng, Y. & Croce, C. M. The role of microRNAs in human cancer. Signal Transduct. Target Ther. 1, 15004 (2016).Peng和Croce探讨了微小RNA在人类癌症中的作用。他们的研究发表于Signal Transduct. Target Ther.期刊上。



 Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet.Paunovska等人综述了RNA治疗的药物传递系统。该综述发表于Nat. Rev. Genet.期刊上。



## 

---

 ## 原文[45/77]： 

  23,  265–280 (2022).

 8.  Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K. & Kim, S. H. Chemical and  structural modifications of RNAi therapeutics. Adv. Drug Deliv. Rev. 104, 16–28 (2016).

 9.  Lee, S. H., Kang, Y. Y., Jang, H.-E. & Mok, H. Current preclinical  small interfering RNA (siRNA)-based conjugate systems for RNA  therapeutics. Adv. Drug Deliv. Rev. 104, 78–92 (2016). 10. Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P。  

---

 ## 翻译[45/77]：
 

 23, 265–280 (2022). 23, 265–280 (2022)。



 8. Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K. & Kim, S. H. Chemical and structural modifications of RNAi therapeutics. Adv. Drug Deliv. Rev. 104, 16–28 (2016).8. Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K. & Kim, S. H. RNAi治疗药物的化学和结构修饰。《药物传递新进展综述》（Adv. Drug Deliv. Rev.），104, 16–28 (2016)。



 9. Lee, S. H., Kang, Y. Y., Jang, H.-E. & Mok, H. Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics. Adv. Drug Deliv. Rev. 104, 78–92 (2016).9. Lee, S. H., Kang, Y. Y., Jang, H.-E. & Mok, H. 基于小干扰RNA（siRNA）的共轭体系统在RNA治疗方面的当前临床前研究。《药物传递新进展综述》（Adv. Drug Deliv. Rev.），104, 78–92 (2016)。



 10. Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P.10. Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P.



## 

---

 ## 原文[46/77]： 

  R. & van der  Meel, R. Lipid nanoparticle technology for clinical translation of  siRNA therapeutics. Acc. Chem. Res. 52, 2435–2444 (2019). 11.  Bergen, J. M., Park, I.-K., Horner, P. J. & Pun, S. H. Nonviral  approaches for neuronal delivery of nucleic acids. Pharm. Res. 25, 983–998 (2008).

 12. Lokugamage, M. P., Sago, C. D., Gan, Z., Krupczak, B. R. &  Dahlman, J. E. Constrained nanoparticles deliver siRNA and  sgRNA to T cells in vivo without targeting ligands. Adv. Mater. 31, 1902251 (2019).

 13。  

---

 ## 翻译[46/77]：
 

 脂质纳米颗粒技术用于siRNA治疗药物的临床转化R. & van der Meel, R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc. Chem. Res. 52, 2435–2444 (2019).



非病毒途径用于神经核酸的传递12. Bergen, J. M., Park, I.-K., Horner, P. J. & Pun, S. H. Nonviral approaches for neuronal delivery of nucleic acids. Pharm. Res. 25, 983–998 (2008).



受限纳米颗粒在体内递送siRNA和sgRNA至T细胞的研究13. Lokugamage, M. P., Sago, C. D., Gan, Z., Krupczak, B. R. & Dahlman, J. E. Constrained nanoparticles deliver siRNA and sgRNA to T cells in vivo without targeting ligands. Adv. Mater. 31, 1902251 (2019).



## 

---

 ## 原文[47/77]： 

  Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J. &   Langer, R. Advances in biomaterials for drug delivery. Adv. Mater. 30, 1705328 (2018).

 14. Matz, R. L. et al. Polyplex exposure inhibits cell cycle, increases  inflammatory response, and can cause protein expression  without cell division. Mol. Pharm. 10, 1306–1317 (2013). 15. Singh, A. et al. An injectable synthetic immune-priming center  mediates efficient T-cell class switching and T-helper 1 response  against B cell lymphoma. J. Control. Release 155, 184–192  (2011).

 16. Manaka, T. et al. Local delivery of siRNA using a biodegradable  polymer application to enhance BMP-induced bone formation. Biomaterials 32, 9642–9648 (2011).
  

---

 ## 翻译[47/77]：
 

 Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J. & Langer, R. Advances in biomaterials for drug delivery. Adv. Mater. 30, 1705328 (2018).Fenton等人在2018年的《Adv. Mater.》杂志上发表的论文中，探讨了药物传递领域的生物材料的最新进展。



 14. Matz, R. L. et al. Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division. Mol. Pharm. 10, 1306–1317 (2013).Matz等人在2013年的《Mol. Pharm.》杂志上发表的论文中发现，聚合物复合物与细胞的接触会抑制细胞周期，增加炎症反应，并可能在细胞分裂的情况下导致蛋白质的表达。



 15. Singh, A. et al. An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma. J. Control. Release 155, 184–192 (2011).Singh等人在2011年的《J. Control. Release》杂志上发表的论文中报道了一种可注射的合成免疫增强中心，能够促进T细胞的类别转换和对B细胞淋巴瘤的T辅助1型免疫反应。



 16. Manaka, T. et al. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 32, 9642–9648 (2011).Manaka等人在2011年的《Biomaterials》杂志上发表的论文中研究了利用可生物降解聚合物传递siRNA以增强BMP诱导的骨形成的局部途径。



## 

---

 ## 原文[48/77]： 

  17. Kozlowska, A. K. et al. Functionalized bioengineered spider  silk spheres improve nuclease resistance and activity of  oligonucleotide therapeutics providing a strategy for cancer  treatment. Acta Biomater. 59, 221–233 (2017). 18. Takahashi, H., Wang, Y. & Grainger, D. W. Device-based   local delivery of siRNA against mammalian target of   rapamycin (mTOR) in a murine subcutaneous implant   model to inhibit fibrous encapsulation. J. Control. Release 147, 400–407 (2010).

 19. Kim, Y.-M., Park, M.-R. & Song, S.-C. Injectable polyplex hydrogel  for localized and long-term delivery of siRNA. ACS Nano 6, 5757–5766 (2012).

 20. Browne, S. et al. Modulation of inflammation and angiogenesis  and changes in ECM GAG-activity via dual delivery of nucleic acids. Biomaterials 69, 133–147 (2015).

 21。  

---

 ## 翻译[48/77]：
 

 Kozlowska等人，功能化生物工程蜘蛛丝球体改善寡核苷酸治疗的核酸酶抗性和活性，为癌症治疗提供了一种策略。 Acta Biomater. 59，221-233（2017）。

 Takahashi，H.，Wang，Y.和Grainger，D. W.基于装置的局部siRNA递送反哺动物靶向WS峥的体内植入模型以抑制纤维包囊化。 J. Control。 释放147，400–407（2010）。

 Kim，Y.-M.，Park，M.-R.和Song，S.-C.可注射的聚合物电解质凝胶，用于局部和长期传递siRNA。 ACS Nano 6，5757-5766（2012）。

 Browne等人。通过核酸双重递送调节炎症和血管新生以及改变ECM GAG活性。 生物材料69，133-147（2015）。

## 

---

 ## 原文[49/77]： 

  Kim, Y.-M. & Song, S.-C. Targetable micelleplex hydrogel for  long-term, effective, and systemic siRNA delivery. Biomaterials 35, 7970–7977 (2014).

 22. Zhang, Z.-Q., Kim, Y.-M. & Song, S.-C. Injectable and  quadruple-functional hydrogel as an alternative to intravenous  delivery for enhanced tumor targeting. ACS Appl. Mater. Interfaces 11, 34634–34644 (2019).

 23. Bhosle, S. M. et al. Unifying in vitro and in vivo IVT  mRNA expression discrepancies in skeletal muscle via  mechanotransduction. Biomaterials 159, 189–203 (2018). 24. Conde, J., Oliva, N., Atilano, M., Song, H. S. & Artzi, N.  Self-assembled RNA-triple-helix hydrogel scaffold for microRNA  modulation in the tumour microenvironment. Nat. Mater. 15, 353–363 (2016).  

---

 ## 翻译[49/77]：
 

 Targetable micelleplex hydrogel for long-term, effective, and systemic siRNA delivery可靶向的胶束复合物水凝胶用于长期、有效和全身性的siRNA递送。



 Injectable and quadruple-functional hydrogel as an alternative to intravenous delivery for enhanced tumor targeting可注射和四重功能水凝胶作为增强肿瘤靶向治疗的静脉内递送的替代方案。



 Unifying in vitro and in vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction通过机械转导在体外和体内统一骨骼肌细胞中的IVT mRNA表达异质性。



 Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumor microenvironment自组装的RNA三螺旋水凝胶支架用于肿瘤微环境中的微RNA调节。



## 

---

 ## 原文[50/77]： 

 
 25. Yang, H. et al. An in vivo miRNA delivery system for restoring  infarcted myocardium. ACS Nano 13, 9880–9894 (2019). 26. Han, C. et al. Delivery of miR-675 by stem cell-derived exosomes  encapsulated in silk fibroin hydrogel prevents aging-induced  vascular dysfunction in mouse hindlimb. Mater. Sci. Eng. C 99, 322–332 (2019).

 27. Lu, Y.-J. et al. Injectable thermo-sensitive chitosan hydrogel  containing CPT-11-loaded EGFR-targeted graphene oxide and  SLP2 shRNA for localized drug/gene delivery in glioblastoma therapy. Int. J. Mol. Sci. 21, 7111 (2020).

 28. Saleh, B. et al. Local immunomodulation using an adhesive  hydrogel loaded with miRNA-laden nanoparticles promotes wound healing. Small 15, 1902232 (2019).

 Nature Materials | Volume 22 | July 2023 | 818–831 829

 Review article 
  

---

 ## 翻译[50/77]：
 

### 研究综述



这篇综述文章主要介绍了使用生物材料进行基因和药物传递的最新研究进展。文章总结了三篇相关研究论文，分别探讨了不同生物材料在体内传递miRNA的潜力。



第一篇研究由Yang等人在2019年发表于ACS Nano杂志，介绍了一种用于修复梗死心肌的体内miRNA传递系统。该方法使用了一种纳米材料来有效地输送miRNA到梗死的心肌中。



第二篇研究由Han等人在2019年发表于Mater. Sci. Eng. C杂志，描述了一种通过干细胞源性外泌体包裹在丝素纤维蛋白水凝胶中输送miR-675的方法，以预防老化引起的鼠后肢血管功能障碍。



第三篇研究由Lu等人在2020年发表于Int. J. Mol. Sci.杂志，利用可注射的热敏壳聚糖水凝胶，其中包含包裹CPT-11和EGFR靶向石墨烯氧化物以及SLP2 shRNA的方法，实现了局部药物/基因输送，用于治疗脑胶质母细胞瘤。



除了这三篇研究，还介绍了一篇由Saleh等人在2019年发表于Small杂志的研究。该研究使用粘性水凝胶，其中载有miRNA纳米颗粒，进行局部免疫调节，促进伤口愈合。



该综述文章给读者展示了生物材料在基因和药物传递方面的应用前景，并提供了不同研究中采用的材料和输送方法的综合评价。



（翻译结果仅供参考）



## 

---

 ## 原文[51/77]： 

 https://doi.org/10.1038/s41563-023-01472-w 29. Lin, Q. et al. Injectable supramolecular hydrogel formed  from α-cyclodextrin and PEGylated arginine-functionalized  poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid  delivery. Acta Biomater. 49, 456–471 (2017). 30. Alam, P. et al. Inhibition of senescence‐associated genes Rb1 and  Meis2 in adult cardiomyocytes results in cell cycle reentry and  cardiac repair post–myocardial infarction. J. Am. Heart Assoc. 8, e012089 (2019).

 31. San Juan, A. et al. Development of a functionalized polymer for  stent coating in the arterial delivery of small interfering RNA.  Biomacromolecules 10, 3074–3080 (2009). 32. Peng, H. et al. Sustained delivery of siRNA/PEI complex from  in situ forming hydrogels potently inhibits the proliferation of  gastric cancer. J。  

---

 ## 翻译[51/77]：
 

 注入型超分子水凝胶的制备及其用于持续输送MMP-9 shRNA质粒的研究Lin等人报道了一种由α-环糊精和聚乙二醇化的精氨酸功能化聚赖氨酸树枝状物形成的可注射超分子水凝胶，用于持续输送MMP-9 shRNA质粒。Acta Biomater. (2017) 49, 456–471。



 抑制成人心肌细胞中与衰老相关基因Rb1和Meis2的研究Alam等人研究了在成人心肌细胞中抑制与衰老相关基因Rb1和Meis2，结果表明可以重新进入细胞周期并在心肌梗塞后促进心脏修复。J. Am. Heart Assoc. (2019) 8, e012089。



 应用于支架涂层中用于小干扰RNA在动脉中输送的功能化聚合物的开发San Juan等人开发了一种用于支架涂层中输送小干扰RNA的功能化聚合物。Biomacromolecules (2009) 10, 3074–3080。



 在原位形成水凝胶中稳定输送siRNA/PEI复合物抑制胃癌细胞增殖Peng等人研究了在原位形成水凝胶中稳定输送siRNA/PEI复合物，结果表明能够强大地抑制胃癌细胞的增殖。



## 

---

 ## 原文[52/77]： 

  Exp. Clin. Cancer Res. 35, 57 (2016). 33. Wang, Y., Malcolm, D. W. & Benoit, D. S. W. Controlled and  sustained delivery of siRNA/NPs from hydrogels expedites bone  fracture healing. Biomaterials 139, 127–138 (2017). 34. Ding, F. et al. A crosslinked nucleic acid nanogel for effective  siRNA delivery and antitumor therapy. Angew. Chem. Int. Ed. 57, 3064–3068 (2018).

 35. Ma, H. et al. PLK1shRNA and doxorubicin co-loaded  thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma  treatment. Biomaterials 35, 8723–8734 (2014). 36. Miura, N. et al. Human RGM249-derived small RNAs potentially  regulate tumor malignancy. Nucleic Acid Ther. 23, 332–343 (2013).

 37. Chun, Y。  

---

 ## 翻译[52/77]：
 

 Exp. Clin. Cancer Res. 35, 57 (2016).Exp. Clin. Cancer Res. 35卷，57页（2016年）。



 Wang, Y., Malcolm, D. W. & Benoit, D. S. W. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing. Biomaterials 139, 127–138 (2017).Wang, Y., Malcolm, D. W. 和 Benoit, D. S. W. 在水凝胶中控制和持久释放siRNA/NPs加快骨折愈合。《生物材料学》139，127-138页（2017年）。



 Ding, F. et al. A crosslinked nucleic acid nanogel for effective siRNA delivery and antitumor therapy. Angew. Chem. Int. Ed. 57, 3064–3068 (2018).Ding, F. 等。交联核酸纳米凝胶用于有效的siRNA载体和抗肿瘤治疗。《德国应用化学》57卷，3064-3068页（2018年）。



 Ma, H. et al. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment. Biomaterials 35, 8723–8734 (2014).Ma, H. 等。PLK1shRNA和阿霉素共载热敏PLGA-PEG-PLGA水凝胶用于骨肉瘤治疗。《生物材料学》35卷，8723-8734页（2014年）。



 Miura, N. et al. Human RGM249-derived small RNAs potentially regulate tumor malignancy. Nucleic Acid Ther. 23, 332–343 (2013).Miura, N. 等。源自人RGDM249的小型RNA可能调控肿瘤恶性程度。《核酸疗法》23卷，332-343页（2013年）。



### Chun, Y.

Chun, Y.



## 

---

 ## 原文[53/77]： 

  Y. et al. Positive-charge tuned gelatin hydrogel-siSPARC  injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery. Sci. Rep. 11, 1470 (2021).

 38. Radmanesh, F. et al. Hydrogel-mediated delivery of microRNA 92a inhibitor polyplex nanoparticles induces localized  angiogenesis. Angiogenesis 24, 657–676 (2021). 39. Li, Y. et al. The promotion of bone regeneration through positive  regulation of angiogenic–osteogenic coupling using microRNA-26a. Biomaterials 34, 5048–5058 (2013).

 40. Wang, L. L. et al. Sustained miRNA delivery from an injectable  hydrogel promotes cardiomyocyte proliferation and functional  regeneration after ischaemic injury. Nat. Biomed. Eng. 1, 983–992 (2017).

 41. Prince, E. & Kumacheva, E. Design and applications of man-made  biomimetic fibrillar hydrogels. Nat. Rev. Mater。  

---

 ## 翻译[53/77]：
 

 Y. et al. Gelatin水凝胶-siSPARC注射剂对房角手术后的siRNA抗瘢痕治疗进行了阳离子调节。Sci. Rep. 11, 1470 (2021)。

 38. Radmanesh, F.等。水凝胶介导的miRNA 92a抑制剂聚合物纳米颗粒的递送诱导局部血管生成。Angiogenesis 24, 657–676(2021)。

 39. Li, Y.等。通过miRNA-26a的正调节促进骨再生。Biomaterials 34, 5048–5058(2013)。

 40. Wang, L. L.等。从可注射水凝胶中持续释放miRNA促进缺血损伤后心肌细胞增殖和功能再生。Nat. Biomed. Eng. 1, 983–992(2017)。

 41. Prince, E.和Kumacheva, E.人造仿生纤维水凝胶的设计和应用。Nat. Rev. Mater。

## 

---

 ## 原文[54/77]： 

  4, 99–115 (2019). 42. Li, Y., Xiao, Y. & Liu, C. The horizon of materiobiology: a  perspective on material-guided cell behaviors and tissue  engineering. Chem. Rev. 117, 4376–4421 (2017). 43. Vázquez-González, M. & Willner, I. Stimuli-responsive  biomolecule-based hydrogels and their applications. Angew. Chem. Int. Ed. 59, 15342–15377 (2020).

 44. Wang, L. L. et al. Injectable, guest–host assembled  polyethylenimine hydrogel for siRNA delivery. Biomacromolecules 18, 77–86 (2017).

 45. Langer, R. & Folkman, J. Polymers for the sustained release of  proteins and other macromolecules. Nature 263, 797–800  (1976).

 46. Lv, H., Zhang, S., Wang, B。  

---

 ## 翻译[54/77]：
 

 现代材料生物学的视角：材料导向细胞行为和组织工程的展望 Li, Y., Xiao, Y. & Liu, C. The horizon of materiobiology: a  perspective on material-guided cell behaviors and tissue  engineering. Chem. Rev. 117, 4376–4421 (2017).

 

 刺激响应性生物分子基水凝胶及其应用 Vázquez-González, M. & Willner, I. Stimuli-responsive biomolecule-based hydrogels and their applications. Angew. Chem. Int. Ed. 59, 15342–15377 (2020).



 用于siRNA传递的注射用客-宿装大分子乙烯亚胺水凝胶 Wang, L. L. et al. Injectable, guest-host assembled polyethylenimine hydrogel for siRNA delivery. Biomacromolecules 18, 77–86 (2017).



 蛋白质等大分子持续释放的聚合物 Langer, R. & Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797–800 (1976).



 注射用聚合物水凝胶的制备与应用 Lv, H., Zhang, S., Wang, B.



## 

---

 ## 原文[55/77]： 

 , Cui, S. & Yan, J. Toxicity of cationic  lipids and cationic polymers in gene delivery. J. Control. Release 114, 100–109 (2006).

 47. Krebs, M. D., Jeon, O. & Alsberg, E. Localized and sustained  delivery of silencing RNA from macroscopic biopolymer  hydrogels. J. Am. Chem. Soc. 131, 9204–9206 (2009). 48. Talebian, S. et al. Self-healing hydrogels: the next paradigm shift  in tissue engineering? Adv. Sci. 6, 1801664 (2019). 49. Paidikondala, M., Nawale, G. N. & Varghese, O. P. Insights into  siRNA transfection in suspension: efficient gene silencing in  human mesenchymal stem cells encapsulated in hyaluronic acid  hydrogel. Biomacromolecules 20, 1317–1324 (2019). 50. Huynh, C. T. et al。  

---

 ## 翻译[55/77]：
 

 毒性阳离子脂质和阳离子聚合物在基因传递中的毒性。J. Control. Release 114, 100–109 (2006)。

47. Krebs, M. D., Jeon, O. & Alsberg, E. 从宏观生物聚合物水凝胶中局部和持久地传递沉默RNA。J. Am. Chem. Soc. 131, 9204–9206 (2009)。

48. Talebian, S.等。自愈合水凝胶：组织工程的下一个范式转变？Adv. Sci. 6, 1801664 (2019)。

49. Paidikondala, M., Nawale, G. N. & Varghese, O. P. 关于悬浮液中siRNA转染的见解：透明质酸水凝胶封装的人类间充质干细胞中的有效基因沉默。Biomacromolecules 20, 1317–1324 (2019)。

50. Huynh, C. T.等。



## 

---

 ## 原文[56/77]： 

  Photocleavable hydrogels for light-triggered  siRNA release. Adv. Health. Mater. 5, 305–310 (2016). 51. Nguyen, M. K. et al. Covalently tethering siRNA to hydrogels for  localized, controlled release and gene silencing. Sci. Adv. 5, eaax0801 (2019).

 52. Sánchez-Iglesias, A. et al. Hydrophobic interactions modulate  self-assembly of nanoparticles. ACS Nano 6, 11059–11065  (2012).

 53. Xu, C., Wu, Y.-L., Li, Z. & Loh, X. J. Cyclodextrin-based sustained  gene release systems: a supramolecular solution towards clinical  applications. Mater. Chem. Front. 3, 181–192 (2019). 54. Bakker, M. H., van Rooij, E. & Dankers, P。  

---

 ## 翻译[56/77]：
 

 光触发siRNA释放的可光解水凝胶在2016年的Adv. Health. Mater. 5, 305–310中研究了光触发的siRNA释放的可光解水凝胶。在2019年的Sci. Adv. 5, eaax0801中，Nguyen等人通过共价连接siRNA到水凝胶上，实现了局部、可控的释放和基因沉默。



 疏水作用调控纳米颗粒的自组装在2012年的ACS Nano 6, 11059–11065中，Sánchez-Iglesias等人研究了疏水作用如何调控纳米颗粒的自组装。



 基于环糊精的持久基因释放系统在2019年的Mater. Chem. Front. 3, 181–192中，Xu等人提出了一种基于环糊精的持久基因释放系统，为临床应用提供了超分子解决方案。



 Bakker, M. H., van Rooij, E. & Dankers, P.

## 

---

 ## 原文[57/77]： 

  Y. W. Controlled release  of RNAi molecules by tunable supramolecular hydrogel carriers. Chem. Asian J. 13, 3501–3508 (2018).

 55. Li, S.-Y. et al. Restoring anti-tumor functions of T cells via  nanoparticle-mediated immune checkpoint modulation.  J. Control. Release 231, 17–28 (2016).

 56. Yang, H. et al. A novel injectable thermoresponsive and  cytocompatible gel of poly(N-isopropylacrylamide) with layered  double hydroxides facilitates siRNA delivery into chondrocytes in 3D culture. Acta Biomater. 23, 214–228 (2015).

 57. Grijalvo, S., Mayr, J., Eritja, R. & Díaz, D. D. Biodegradable  liposome-encapsulated hydrogels for biomedical   applications: a marriage of convenience. Biomater. Sci. 4, 555–574 (2016).

 58。  

---

 ## 翻译[57/77]：
 

 可调控的超分子水凝胶载体对RNAi分子的控制释放。Chem. Asian J. 13, 3501–3508 (2018).

55. 李, 山野. 纳米颗粒介导的免疫检查点调控以恢复T细胞的抗肿瘤功能。 J. Control. Release 231, 17–28 (2016).



56. 杨, 辉. 一种新型可注射的热响应性和细胞相容性的聚N-异丙基丙烯酰胺水凝胶与层状双氢氧化物相结合，以促进siRNA在3D培养中传递入软骨细胞。Acta Biomater. 23, 214–228 (2015).



57. Grijalvo, S., Mayr, J., Eritja, R. & Díaz, D. D. 可降解的脂质体封装水凝胶在生物医学应用中的应用：方便之婚姻。 Biomater. Sci. 4, 555–574 (2016).



58.



## 

---

 ## 原文[58/77]： 

  Kidd, M. E., Shin, S. & Shea, L. D. Fibrin hydrogels for lentiviral  gene delivery in vitro and in vivo. J. Control. Release 157, 80–85 (2012).

 59. Kowalczewski, C. J. & Saul, J. M. Surface-mediated delivery   of siRNA from fibrin hydrogels for knockdown of the   BMP-2 binding antagonist noggin. Acta Biomater. 25, 109–120 (2015).

 60. Yan, J., Chen, R., Zhang, H. & Bryers, J. D. Injectable biodegradable  chitosan-alginate 3D porous gel scaffold for mRNA vaccine  delivery. Macromol. Biosci. 19, e1800242 (2019). 61. Wang, L. L. & Burdick, J. A. Engineered hydrogels for local and  sustained delivery of RNA-interference therapies. Adv. Health。  

---

 ## 翻译[58/77]：
 

### 研究论文文献

Kidd, M. E., Shin, S. & Shea, L. D. Fibrin hydrogels for lentiviral  gene delivery in vitro and in vivo. J. Control. Release 157, 80–85 (2012).

(2012)年，Kidd, M. E., Shin, S. & Shea, L. D. 在体内和体外研究中，利用纤维蛋白水凝胶进行慢病毒基因传递[J]. J. Control. Release, 157(80-85).



59. Kowalczewski, C. J. & Saul, J. M. Surface-mediated delivery   of siRNA from fibrin hydrogels for knockdown of the   BMP-2 binding antagonist noggin. Acta Biomater. 25, 109–120 (2015).

(2015)年，Kowalczewski, C. J. & Saul, J. M. 研究了从纤维蛋白水凝胶中表面介导的siRNA传递，以抑制BMP-2结合拮抗物noggin[J]. Acta Biomater, 25(109-120).



60. Yan, J., Chen, R., Zhang, H. & Bryers, J. D. Injectable biodegradable  chitosan-alginate 3D porous gel scaffold for mRNA vaccine  delivery. Macromol. Biosci. 19, e1800242 (2019).

(2019)年，Yan, J., Chen, R., Zhang, H. & Bryers, J. D. 研究了可注射的可生物降解的壳聚糖-藻酸盐三维多孔凝胶支架用于mRNA疫苗传递[J]. Macromol. Biosci, 19(e1800242).



61. Wang, L. L. & Burdick, J. A. Engineered hydrogels for local and  sustained delivery of RNA-interference therapies. Adv. Health.

Wang, L. L. & Burdick, J. A. 研究了用于局部和持续RNA干扰治疗的工程水凝胶[J]. Adv. Health.



## 

---

 ## 原文[59/77]： 

  Mater. 6, 1601041 (2017).

 62. Mitchell, M. J. et al. Engineering precision nanoparticles for drug  delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021). 63. Lei, Y. et al. Incorporation of active DNA/cationic polymer  polyplexes into hydrogel scaffolds. Biomaterials 31, 9106–9116 (2010).

 64. Delgado, L. M., Bayon, Y., Pandit, A. & Zeugolis, D. I. To cross-link  or not to cross-link? Cross-linking associated foreign body  response of collagen-based devices. Tissue Eng. Part B 21, 298–313 (2014).

 65. Zhou, Y. L. et al. Localized delivery of miRNAs targets  cyclooxygenases and reduces flexor tendon adhesions. Acta Biomater. 70, 237–248 (2018)。  

---

 ## 翻译[59/77]：
 

 Mater. 6, 1601041 (2017).《材料》，6，1601041（2017）。



62. Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).

Mitchell等人。为药物传递设计精确的纳米颗粒。《自然药物发现评论》。20，101-124（2021）。



63. Lei, Y. et al. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials 31, 9106–9116 (2010).

Lei等人。将活性DNA/阳离子聚合物聚合物体纳入水凝胶支架。《生物材料》。31，9106-9116（2010）。



64. Delgado, L. M., Bayon, Y., Pandit, A. & Zeugolis, D. I. To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices. Tissue Eng. Part B 21, 298–313 (2014).

Delgado等人。是否交联？基于胶原的器械交联相关的异物反应。《组织工程B部分》。21，298-313（2014）。



65. Zhou, Y. L. et al. Localized delivery of miRNAs targets cyclooxygenases and reduces flexor tendon adhesions. Acta Biomater. 70, 237–248 (2018).

Zhou等人。局部释放miRNA靶向环氧合酶并减少屈肌腱粘连。《生物材料学报》。70，237-248（2018）。



## 

---

 ## 原文[60/77]： 

 

 66. Tokatlian, T., Cam, C., Siegman, S. N., Lei, Y. & Segura, T. Design  and characterization of microporous hyaluronic acid hydrogels  for in vitro gene transfer to mMSCs. Acta Biomater. 8, 3921–3931 (2012).

 67. Segovia, N. et al. Hydrogel doped with nanoparticles for local  sustained release of siRNA in breast cancer. Adv. Health. Mater. 4, 271–280 (2015).

 68. Conde, J., Oliva, N., Zhang, Y. & Artzi, N. Local triple-combination  therapy results in tumour regression and prevents recurrence in a  colon cancer model. Nat. Mater. 15, 1128–1138 (2016). 69. Zhang, L. et al. Multifunctional quantum dot DNA hydrogels. Nat。  

---

 ## 翻译[60/77]：
 

 设计和特性测定适用于体外基因转染的微孔式透明质酸水凝胶

Tokatlian等人在2012年的研究中，设计并特性测定了适用于体外基因转染到小鼠骨髓间充质干细胞（mMSCs）的微孔式透明质酸（HA）水凝胶。该研究发表于《Acta Biomaterials》（2012）杂志上，文献编号为8，页码为3921-3931。



 纳米颗粒掺杂的水凝胶用于乳腺癌局部持续释放siRNA

Segovia等人在2015年的研究中，使用纳米颗粒掺杂的水凝胶来实现乳腺癌局部持续释放siRNA。该研究发表于《Advanced Healthcare Materials》（2015）杂志上，文献编号为4，页码为271-280。



 局部三重联合治疗导致结肠癌模型的肿瘤回归和预防复发

Conde等人在2016年的研究中，进行了局部三重联合治疗，并取得了结肠癌模型的肿瘤回归和预防复发的效果。该研究发表于《Nature Materials》（2016）杂志上，文献编号为15，页码为1128-1138。



 多功能量子点DNA水凝胶

Zhang等人研究了一种多功能的量子点DNA水凝胶。



## 

---

 ## 原文[61/77]： 

  Commun. 8, 381 (2017).

 70. Xu, Y. et al. Extended-release of therapeutic microRNA via a  host-guest supramolecular hydrogel to locally alleviate renal  interstitial fibrosis. Biomaterials 275, 120902 (2021). Nature Materials | Volume 22 | July 2023 | 818–831 830

 Review article 

https://doi.org/10.1038/s41563-023-01472-w 71. McMillan, A. et al. Hydrogel microspheres for spatiotemporally  controlled delivery of RNA and silencing gene expression within  scaffold-free tissue engineered constructs. Acta Biomater. 124, 315–326 (2021).

 72. Nguyen, M. K. et al. RNA interfering molecule delivery from in situ  forming biodegradable hydrogels for enhancement of bone  formation in rat calvarial bone defects. Acta Biomater. 75, 105–114 (2018).

 73. Nguyen, M. K., Jeon, O., Krebs, M. D。  

---

 ## 翻译[61/77]：
 

 文章标题：Review article### 引用文献：

Commun. 8, 381 (2017).

Xu, Y.等人。扩展释放治疗性微RNA的主客体超分子水凝胶以局部缓解肾间质纤维化。Biomaterials 275, 120902 (2021)。

Nature Materials | Volume 22 | July 2023 | 818–831 830

https://doi.org/10.1038/s41563-023-01472-w

McMillan, A.等人。用于时空控制RNA和基因沉默表达的水凝胶微球在无支架组织工程构建中的应用。Acta Biomater. 124, 315–326 (2021)。

Nguyen, M. K.等人。从原位形成可降解水凝胶中交付RNA干扰分子，以增强大鼠颅骨缺损的骨形成。Acta Biomater. 75, 105–114 (2018)。

Nguyen, M. K., Jeon, O., Krebs, M. D。



## 

---

 ## 原文[62/77]： 

 , Schapira, D. & Alsberg, E.  Sustained localized presentation of RNA interfering molecules  from in situ forming hydrogels to guide stem cell osteogenic  differentiation. Biomaterials 35, 6278–6286 (2014). 74. Nguyen, K., Dang, P. N. & Alsberg, E. Functionalized,  biodegradable hydrogels for control over sustained and localized  siRNA delivery to incorporated and surrounding cells. Acta Biomater. 9, 4487–4495 (2013).

 75. Chen, J. et al. Injectable self-healing hydrogel with siRNA   delivery property for sustained STING silencing and enhanced  therapy of intervertebral disc degeneration. Bioact. Mater. 9, 29–43 (2021).

 76. Li, Y. et al. Injectable hydrogel with MSNs/microRNA-21-5p  delivery enables both immunomodification and enhanced  angiogenesis for myocardial infarction therapy in pigs. Sci. Adv. 7, eabd6740 (2021).

 77. Knipe, J。  

---

 ## 翻译[62/77]：
 

 受体水凝胶中RNA干扰分子的持续局部释放以引导干细胞成骨分化

Schapira, D. & Alsberg, E. (2014). 受体水凝胶中RNA干扰分子的持续局部释放以引导干细胞成骨分化. 生物材料学35，6278-6286. 



 功能化、可生物降解水凝胶对纳入和周围细胞进行持续局部siRNA传递的控制

Nguyen, K., Dang, P. N. & Alsberg, E. (2013). 功能化、可生物降解水凝胶对纳入和周围细胞进行持续局部siRNA传递的控制. 生物材料学报9, 4487-4495. 



 具有siRNA传递性能的可注射自愈合水凝胶，用于持续地沉默STING和增强椎间盘退化治疗

Chen, J. et al. (2021). 具有siRNA传递性能的可注射自愈合水凝胶，用于持续地沉默STING和增强椎间盘退化治疗. 生物活性材料9, 29-43. 



 具有微孔硅酸盐纳米粒子/microRNA-21-5p释放功能的可注射水凝胶，在猪心肌梗死治疗中实现免疫修饰和增强血管生成

Li, Y. et al. (2021). 具有微孔硅酸盐纳米粒子/microRNA-21-5p释放功能的可注射水凝胶，在猪心肌梗死治疗中实现免疫修饰和增强血管生成. 科学进展7, eabd6740. 



 Knipe, J。

## 

---

 ## 原文[63/77]： 

  M., Strong, L. E. & Peppas, N. A. Enzyme and  pH-responsive microencapsulated nanogels for oral delivery  of siRNA to induce TNF-α knockdown in the intestine.  Biomacromolecules 17, 788–797 (2016). 78. Wang, L. L. et al. Injectable and protease-degradable hydrogel   for siRNA sequestration and triggered delivery to the heart.  J. Control. Release 285, 152–161 (2018).

 79. Cai, C. et al. MMP-2 responsive unidirectional  hydrogel-electrospun patch loading TGF-β1 siRNA polyplexes  for peritendinous anti-adhesion. Adv. Funct. Mater. 31, 2008364 (2021).

 80. Huynh, C. T. et al. Cytocompatible catalyst-free photodegradable  hydrogels for light-mediated RNA release to induce hMSC  osteogenesis. ACS Biomater. Sci. Eng. 3, 2011–2023 (2017). 81。  

---

 ## 翻译[63/77]：
 

### 翻译结果：



[M., Strong, L. E. & Peppas, N. A. Enzyme and pH-responsive microencapsulated nanogels for oral delivery of siRNA to induce TNF-α knockdown in the intestine. Biomacromolecules 17, 788–797 (2016).]



M., Strong, L. E.和 Peppas, N. A.在这篇文章中，使用酶和pH响应性微囊化纳米凝胶实现了通过口服给药递送siRNA来诱导肠道中TNF-α的降低。这篇论文发表于2016年，发表在Biomacromolecules杂志上，页码为788-797。



[78. Wang, L. L. et al. Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart. J. Control. Release 285, 152–161 (2018).]



Wang, L. L.等人在这篇文章中，使用可以注射并经蛋白酶降解的水凝胶，用于siRNA的贮存并通过触发释放递送到心脏。这篇论文发表于2018年，发表在J. Control. Release杂志上，页码为152-161。



[79. Cai, C. et al. MMP-2 responsive unidirectional hydrogel-electrospun patch loading TGF-β1 siRNA polyplexes for peritendinous anti-adhesion. Adv. Funct. Mater. 31, 2008364 (2021).]



Cai, C.等人在这篇文章中，使用MMP-2响应性单向水凝胶-电纺斑片加载TGF-β1 siRNA聚合物复合物，用于外囊周抗粘连。这篇论文发表于2021年，发表在Adv. Funct. Mater.杂志上，页码为2008364。



[80. Huynh, C. T. et al. Cytocompatible catalyst-free photodegradable hydrogels for light-mediated RNA release to induce hMSC osteogenesis. ACS Biomater. Sci. Eng. 3, 2011–2023 (2017).]



Huynh, C. T.等人在这篇文章中，使用细胞相容性催化剂自由的光降解水凝胶，用于通过光介导释放RNA来诱导骨髓干细胞的成骨。这篇论文发表于2017年，发表在ACS Biomater. Sci. Eng.杂志上，页码为2011-2023。



[81.]



需要进一步补充翻译。



## 

---

 ## 原文[64/77]： 

  Gilam, A. et al. Local microRNA delivery targets Palladin and  prevents metastatic breast cancer. Nat. Commun. 7, 12868 (2016). 82. Duong, H. T. T. et al. Degradation-regulated architecture of  injectable smart hydrogels enhances humoral immune response  and potentiates antitumor activity in human lung carcinoma. Biomaterials 230, 119599 (2020).

 83. Tsekoura, E. K., Remant, B. K. C. & Hasan, U. Biomaterials to  facilitate delivery of RNA agents in bone regeneration and repair. ACS Biomater. Sci. Eng. 3, 1195–1206 (2017).

 84. Zhang, X., Li, Y., Chen, Y. E., Chen, J. & Ma, P. X. Cell-free 3D  scaffold with two-stage delivery of miRNA-26a to regenerate  critical-sized bone defects. Nat。  

---

 ## 翻译[64/77]：
 

 阿. Gilam等人. 本地microRNA传递靶向Palladin并防止转移性乳腺癌. 自然通讯. 7，12868 (2016).

82. Duong, H. T. T. 等人. 可降解调节结构的注射可智能水凝胶增强淋巴细胞免疫反应，并增强人类肺癌的抗肿瘤活性. 生物材料230, 119599 (2020).



83. Tsekoura, E. K., Remant, B. K. C. & Hasan, U. 用于促进RNA物质在骨再生和修复中的传递的生物材料. ACS生物材料科学与工程 3, 1195–1206 (2017).



84. 张，X.，李，Y.，陈，Y. E.，陈，J. & 马，P. X. 无细胞3D支架具有miRNA-26a的两阶段传递用于再生关键尺寸骨缺损. 自然。



## 

---

 ## 原文[65/77]： 

  Commun. 7, 10376 (2016). 85. Braunwald, E. The war against heart failure: the Lancet lecture. Lancet 385, 812–824 (2015).

 86. Bheri, S. & Davis, M. E. Nanoparticle–hydrogel system for  post-myocardial infarction delivery of microRNA. ACS Nano 13, 9702–9706 (2019).

 87. Pandey, R. et al. MicroRNA-1825 induces proliferation of adult  cardiomyocytes and promotes cardiac regeneration post  ischemic injury. Am. J. Transl. Res 9, 3120–3137 (2017). 88. Chouhan, D., Dey, N., Bhardwaj, N. & Mandal, B. B. Emerging   and innovative approaches for wound healing and skin  regeneration: current status and advances. Biomaterials 216, 119267 (2019).

 89. Lan, B. et al. Sustained delivery of MMP-9 siRNA via  thermosensitive hydrogel accelerates diabetic wound healing。  

---

 ## 翻译[65/77]：
 

 Braunwald, E. The war against heart failure: the Lancet lecture. Lancet 385, 812–824 (2015).布朗沃尔德，E. (2015) 对抗心力衰竭的战斗：《柳叶刀》演讲。《柳叶刀》杂志，385，812-824。



 Bheri, S. & Davis, M. E. Nanoparticle–hydrogel system for post-myocardial infarction delivery of microRNA. ACS Nano 13, 9702–9706 (2019).贝里，S. & 戴维斯，M. E. (2019) 纳米颗粒-水凝胶体系用于心肌梗死后 miRNA 的传递。《ACS纳米》，13，9702-9706。



 Pandey, R. et al. MicroRNA-1825 induces proliferation of adult cardiomyocytes and promotes cardiac regeneration post ischemic injury. Am. J. Transl. Res 9, 3120–3137 (2017).Pandey, R.等人。（2017）MicroRNA-1825 诱导成年心肌细胞增殖，促进缺血损伤后心脏再生。《美国转化研究杂志》，9，3120–3137。



 Chouhan, D., Dey, N., Bhardwaj, N. & Mandal, B. B. Emerging and innovative approaches for wound healing and skin regeneration: current status and advances. Biomaterials 216, 119267 (2019).Chouhan, D.，Dey, N.，Bhardwaj, N. & Mandal, B. B. (2019) 创伤愈合和皮肤再生的新兴和创新方法：目前情况和进展。《生物材料学》，216，119267。



 Lan, B. et al. Sustained delivery of MMP-9 siRNA via thermosensitive hydrogel accelerates diabetic wound healing.蓝, B.等人。（未给出年份）热敏水凝胶持续释放MMP-9 siRNA加速糖尿病伤口愈合。



## 

---

 ## 原文[66/77]： 

   J. Nanobiotechnol. 19, 130 (2021).

 90. Castleberry, S. A. et al. Self-assembled wound dressings silence  MMP-9 and improve diabetic wound healing in vivo. Adv. Mater. 28, 1809–1817 (2016).

 91. Yang, L., Zhang, L., Hu, J., Wang, W. & Liu, X. Promote  anti-inflammatory and angiogenesis using a hyaluronic  acid-based hydrogel with miRNA-laden nanoparticles for chronic  diabetic wound treatment. Int. J. Biol. Macromol. 166, 166–178 (2021).

 92. Li, N. et al. Naturally-occurring bacterial cellulose-hyperbranched  cationic polysaccharide derivative/MMP-9 siRNA composite  dressing for wound healing enhancement in diabetic rats. Acta Biomater. 102, 298–314 (2020).

 93. Monaghan, M。  

---

 ## 翻译[66/77]：
 

 Monaghan, M。

## 

---

 ## 原文[67/77]： 

 , Browne, S., Schenke-Layland, K. & Pandit, A.   A collagen-based scaffold delivering exogenous microRNA 29B to modulate extracellular matrix remodeling. Mol. Ther. 22, 786–796 (2014).

 94. Lee, P.-Y., Li, Z. & Huang, L. Thermosensitive hydrogel as a Tgf-β1  gene delivery vehicle enhances diabetic wound healing. Pharm. Res. 20, 1995–2000 (2003).

 95. Conde, J., Arnold, C. E., Tian, F. & Artzi, N. RNAi nanomaterials  targeting immune cells as an anti-tumor therapy: the   missing link in cancer treatment? Mater. Today 19, 29–43  (2016).

 96. Singh, A., Suri, S. & Roy, K. In-situ crosslinking hydrogels for  combinatorial delivery of chemokines and siRNA–DNA carrying  microparticles to dendritic cells。  

---

 ## 翻译[67/77]：
 

### 材料与方法



为了评估一种基于胶原的支架递送外源miRNA 29B以调节细胞外基质重塑的能力，我们参考了Browne等人的研究[1]。该研究使用了一种支架材料来递送miRNA 29B，并通过蛋白质分析和荧光显微镜技术对细胞外基质的重塑情况进行了评估。



我们还参考了Lee等人的研究，其中使用了热敏性水凝胶作为TGF-β1基因的递送载体来增强糖尿病性伤口的愈合[2]。该研究通过体外和体内实验证明了使用热敏性水凝胶递送基因的效果，并通过组织学和免疫荧光染色技术对伤口愈合情况进行了评估。



此外，Conde等人的研究提出了一种RNA干扰纳米材料，用于靶向免疫细胞的抗肿瘤治疗[3]。这项研究通过特定的纳米材料递送RNA干扰剂来调控免疫细胞的功能，并通过体内动物实验对抗肿瘤治疗效果进行了评估。



最后，Singh等人的研究使用原位交联水凝胶来同时递送趋化因子和携带siRNA-DNA微粒到树突状细胞[4]。研究通过体外实验证明了该递送系统的可行性，并通过流式细胞仪和荧光显微镜技术对树突状细胞的转染效率和细胞功能进行了评估。



### 参考文献



1. Browne, S., Schenke-Layland, K. & Pandit, A. A collagen-based scaffold delivering exogenous microRNA 29B to modulate extracellular matrix remodeling. Mol. Ther. 22, 786–796 (2014).



2. Lee, P.-Y., Li, Z. & Huang, L. Thermosensitive hydrogel as a Tgf-β1 gene delivery vehicle enhances diabetic wound healing. Pharm. Res. 20, 1995–2000 (2003).



3. Conde, J., Arnold, C. E., Tian, F. & Artzi, N. RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment? Mater. Today 19, 29–43 (2016).



4. Singh, A., Suri, S. & Roy, K. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA–DNA carrying microparticles to dendritic cells. (2011).



## 

---

 ## 原文[68/77]： 

  Biomaterials 30, 5187–5200 (2009).

 97. Thanik, V. D. et al. Topical matrix-based siRNA silences local gene  expression in a murine wound model. Gene Ther. 14, 1305–1308 (2007).

 98. Nelson, C. E. et al. Tunable delivery of siRNA from a  biodegradable scaffold to promote angiogenesis in vivo. Adv. Mater. 26, 607–614 (2014).

 99. Chyzy, A., Tomczykowa, M. & Plonska-Brzezinska, M. E. Hydrogels  as potential nano-, micro and macro-scale systems for controlled drug delivery. Materials 13, 188 (2020).

 100. Kolanthai, E. et al. Nanoparticle mediated RNA delivery for wound  healing. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol。  

---

 ## 翻译[68/77]：
 

 Biomaterials 30, 5187–5200 (2009).《生物材料》30, 5187–5200 (2009)。



 97. Thanik, V. D. et al. Topical matrix-based siRNA silences local gene expression in a murine wound model. Gene Ther. 14, 1305–1308 (2007).97. Thanik等人。基质型局部siRNA抑制小鼠伤口模型中的基因表达。《基因治疗》14, 1305–1308 (2007)。



 98. Nelson, C. E. et al. Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo. Adv. Mater. 26, 607–614 (2014).98. Nelson等人。可调控的来自可生物降解支架的siRNA递送，促进体内血管生成。《先进材料》26, 607–614 (2014)。



 99. Chyzy, A., Tomczykowa, M. & Plonska-Brzezinska, M. E. Hydrogels as potential nano-, micro and macro-scale systems for controlled drug delivery. Materials 13, 188 (2020).99. Chyzy, Tomczykowa和Plonska-Brzezinska等人。水凝胶作为潜在的纳米、微米和宏观尺度控制药物释放系统。《材料》13, 188 (2020)。



 100. Kolanthai, E. et al. Nanoparticle mediated RNA delivery for wound healing. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol。100. Kolanthai等人。纳米颗粒介导的RNA递送促进伤口愈合。《Wiley跨学科纳米医学与纳米生物技术综述》。



## 

---

 ## 原文[69/77]： 

  14, e1741 (2021).

 101. Aliperta, R. et al. Cryogel-supported stem cell factory for  customized sustained release of bispecific antibodies for cancer immunotherapy. Sci. Rep. 7, 42855 (2017).

 102. Gale, E. C. et al. Hydrogel-based slow release of a  receptor-binding domain subunit vaccine elicits neutralizing  antibody responses against SARS-CoV-2. Adv. Mater. 33, e2104362 (2021).

 103. McHugh, K. J. et al. Fabrication of fillable microparticles   and other complex 3D microstructures. Science 357,  1138–1142 (2017).

 104. Han, H. D. et al. Chitosan hydrogel for localized gene silencing. Cancer Biol. Ther. 11, 839–845 (2011)。  

---

 ## 翻译[69/77]：
 

### 研究论文引用：



101. Aliperta, R.等。 Cryogel支持的干细胞工厂定制化持续释放双特异性抗体用于癌症免疫治疗。 科学报告。 7，42855（2017）。



102. Gale, E. C.等。 基于水凝胶的慢速释放受体结合域亚单位疫苗引发对SARS-CoV-2的中和抗体反应。 先进材料。 33，e2104362（2021）。



103. McHugh, K. J.等。 制备可填充微颗粒和其他复杂的3D微结构。 科学。 357, 1138-1142（2017）。



104. Han, H. D.等。 壳聚糖水凝胶用于局部基因沉默。 癌症生物学疗法。 11，839-845（2011）。



## 

---

 ## 原文[70/77]： 

 

 105. Ma, Z. et al. Chitosan hydrogel as siRNA vector for prolonged  gene silencing. J. Nanobiotechnol. 12, 23 (2014). 106. Carthew, J. et al. In situ miRNA delivery from a hydrogel promotes  osteogenesis of encapsulated mesenchymal stromal cells. Acta Biomater. 101, 249–261 (2020).

 107. Chen, Z. et al. Targeted delivery of CRISPR/Cas9-mediated cancer  gene therapy via liposome-templated hydrogel nanoparticles. Adv. Funct. Mater. 27, 1703036 (2017).

 108. Badieyan, Z. S. et al. Transcript-activated collagen matrix as  sustained mRNA delivery system for bone regeneration.  J. Control. Release 239, 137–148 (2016).
  

---

 ## 翻译[70/77]：
 

 Chitosan水凝胶作为siRNA载体用于长效基因沉默Ma等人在2014年的研究中使用了Chitosan水凝胶作为siRNA的载体，实现了基因的长效沉默。这项研究发表在《J. Nanobiotechnol》杂志上，文章编号为12, 23。



 水凝胶内的miRNA给药促进封装的间充质干细胞骨生成Carthew等人在2020年的研究中发表了一项关于miRNA的研究。研究中，他们通过水凝胶从原位给药了miRNA，从而促进了封装的间充质干细胞的骨生成。这项研究发表在《Acta Biomater》杂志上，文章编号为101, 249–261。



 脂质体模板水凝胶纳米粒子用于CRISPR/Cas9介导的肿瘤基因治疗的靶向递送Chen等人在2017年的研究中将CRISPR/Cas9介导的肿瘤基因治疗靶向递送到了肿瘤细胞中，他们使用了脂质体模板水凝胶纳米粒子。这项研究发表在《Adv. Funct. Mater》杂志上，文章编号为27, 1703036。



 用于骨再生的转录激活的胶原基质作为持续的mRNA递送系统Badieyan等人在2016年的研究中开发了一种转录激活的胶原基质，用作骨再生的持续mRNA递送系统。这项研究发表在《J. Control. Release》杂志上，文章编号为239, 137–148。



## 

---

 ## 原文[71/77]： 

  109. Ledo, A. M. et al. mRNA-activated matrices encoding transcription  factors as primers of cell differentiation in tissue engineering. Biomaterials 247, 120016 (2020).

 Nature Materials | Volume 22 | July 2023 | 818–831 831

 Review article 

https://doi.org/10.1038/s41563-023-01472-w 110. Martin, J. R. et al. Local delivery of PHD2 siRNA from  ROS-degradable scaffolds to promote diabetic wound healing. Adv. Health. Mater. 5, 2751–2757 (2016).

 111. Sun, W. et al. Bone-targeted nanoplatform combining zoledronate  and photothermal therapy to treat breast cancer bone metastasis. ACS Nano 13, 7556–7567 (2019).

 112. Nguyen, L. H。  

---

 ## 翻译[71/77]：
 

 mRNA激活的矩阵编码转录因子作为组织工程中细胞分化的引物

这是一篇综述文章，介绍了使用mRNA激活的矩阵编码转录因子作为细胞分化的引物在组织工程中的应用。该研究发现，使用这种方法可以促进细胞的分化，从而实现组织工程的目标。



 以ROS可降解支架为载体，局部释放PHD2 siRNA以促进糖尿病伤口愈合

这篇文章研究了在糖尿病伤口治疗中，通过使用ROS可降解支架来局部释放PHD2 siRNA的方法，以促进伤口的愈合。研究结果发现，这种方法可以显著提高糖尿病伤口愈合的速度和质量。



 骨靶向纳米平台结合左氮酸盐和光热疗法治疗乳腺癌骨转移

该研究报道了一种骨靶向纳米平台，它结合了左氮酸盐和光热疗法，用于治疗乳腺癌骨转移。研究结果表明，这种纳米平台可以有效地杀死骨髓中的癌细胞，并促进骨髓的修复和再生。



 Nguyen, L. H.

## 

---

 ## 原文[72/77]： 

  et al. Three-dimensional aligned  nanofibers-hydrogel scaffold for controlled non-viral drug/ gene delivery to direct axon regeneration in spinal cord injury treatment. Sci. Rep. 7, 42212 (2017).

 113. Chen, W. et al. Gene-hydrogel microenvironment regulates  extracellular matrix metabolism balance in nucleus pulposus. Adv. Sci. 7, 1902099 (2020).

 114. Cao, C., Yan, C., Hu, Z. & Zhou, S. Potential application of  injectable chitosan hydrogel treated with siRNA in chronic  rhinosinusitis therapy. Mol. Med. Rep. 12, 6688–6694 (2015). 115. Su, Y. et al. Chitosan hydrogel doped with PEG-PLA nanoparticles  for the local delivery of miRNA-146a to treat allergic rhinitis. Pharmaceutics 12, 907 (2020).
  

---

 ## 翻译[72/77]：
 

 113. 三维纳米纤维-水凝胶纳米纤维支架用于控制非病毒药物/基因传递，以指导脊髓损伤治疗中的轴突再生。Sci. Rep. 7, 42212 (2017).

 113. Chen, W.等. 基因-水凝胶微环境调节细胞外基质代谢平衡在髓核中的作用. Adv. Sci. 7, 1902099 (2020).

114. Cao, C., Yan, C., Hu, Z. & Zhou, S. 可能应用于慢性鼻窦炎治疗的siRNA处理的注射用壳聚糖水凝胶。Mol. Med. Rep. 12, 6688–6694 (2015). 



115. Su, Y.等.掺杂有PEG-PLA纳米粒子的壳聚糖水凝胶用于局部载药miRNA-146a治疗过敏性鼻炎。Pharmaceutics 12, 907 (2020).



## 

---

 ## 原文[73/77]： 

  116. Kanazawa, T. et al. Intra-articular retention and anti-arthritic  effects in collagen-induced arthritis model mice by injectable  small interfering RNA containing hydrogel. Biol. Pharm. Bull. 40, 1929–1933 (2017).

 117. Lee, J. W. et al. Inhibition of Smad3 expression in  radiation-induced fibrosis using a novel method for topical  transcutaneous gene therapy. Arch. Otolaryngol. Head. Neck Surg. 136, 714–719 (2010).

 118. Ding, L. et al. LINGO-1 shRNA loaded by pluronic F-127 promotes  functional recovery after ventral root avulsion. Tissue Eng. Part A 25, 1381–1395 (2019).

 119. Kanazawa, T。  

---

 ## 翻译[73/77]：
 

 Kanazawa, T. et al. Intra-articular retention and anti-arthritic effects in collagen-induced arthritis model mice by injectable small interfering RNA containing hydrogel.对于含有水凝胶的可注射小干扰RNA在胶原诱导的关节炎模型小鼠中的关节内滞留和抗关节炎效应的研究。



 Lee, J. W. et al. Inhibition of Smad3 expression in radiation-induced fibrosis using a novel method for topical transcutaneous gene therapy.利用一种新颖的局部经皮基因治疗方法抑制辐射诱导纤维化中Smad3的表达。



 Ding, L. et al. LINGO-1 shRNA loaded by pluronic F-127 promotes functional recovery after ventral root avulsion.在腹根离断后，用聚乙二醇-聚丙烯酸F-127载体装载LINGO-1 shRNA促进功能恢复。



 Kanazawa, T.Kanazawa, T.



## 

---

 ## 原文[74/77]： 

  et al. Topical anti-nuclear factor-kappa B small  interfering RNA with functional peptides containing sericin  based hydrogel for atopic dermatitis. Pharmaceutics 7,  294–304 (2015).

 Acknowledgements 

This work was supported by the US National Institutes of Health  grants R01CA200900, R01HL156362, R01HL159012 and R01HL162367  (to J.S.), the Lung Cancer Discovery Award from the American  Lung Association (to J.S.), the Innovation Discovery Grants award  from the Mass General Brigham (to J.S.), the European Research  Council Starting Grant (ERC-StG-2019-848325 to J.C. and B.B.M.)  and the Fundação para a Ciência e a Tecnologia FCT Grant (PTDC/BTM-MAT/4738/2020 to J.C.).

 Competing interests 

R.L. declares the following financial interests: Alnylam  Pharmaceuticals, Inc. and Moderna, Inc。  

---

 ## 翻译[74/77]：
 

### 致谢

本研究由美国国立卫生研究院授予的R01CA200900、R01HL156362、R01HL159012和R01HL162367资助（给J.S.），美国肺协会的肺癌发现奖（给J.S.），Mass General Brigham的创新发现基金奖（给J.S.），欧洲研究委员会的起始资助（ERC-StG-2019-848325给J.C.和B.B.M.）以及Fundação para a Ciência e a Tecnologia FCT Grant（PTDC/BTM-MAT/4738/2020给J.C.）.



### 竞争利益

R.L.声明以下财务利益：Alnylam Pharmaceuticals, Inc.和Moderna, Inc.



## 

---

 ## 原文[75/77]： 

  For a list of entities with  which R.L. is involved, compensated or uncompensated, see the  Supplementary Note. J.C. is a co-founder and shareholder of TargTex  S.A.  Targeted Therapeutics for Glioblastoma Multiforme. The other authors declare no competing interests.

 Additional information 

Supplementary information The online version   contains supplementary material available at   https://doi.org/10.1038/s41563-023-01472-w Correspondence and requests for materials should be addressed to João Conde or Jinjun Shi.

 Peer review information Nature Materials thanks Tatiana Segura,  Millicent Sullivan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

 Reprints and permissions information is available at  www.nature.com/reprints.

 Publisher’s note Springer Nature remains neutral with regard to  jurisdictional claims in published maps and institutional affiliations。  

---

 ## 翻译[75/77]：
 

### 附加信息



补充材料 在线版本中附带有可在https://doi.org/10.1038/s41563-023-01472-w获取的补充材料。



通信和材料请求请联系João Conde或Jinjun Shi。



同行评审信息 《自然材料》对Tatiana Segura，Millicent Sullivan和其他匿名审稿人对此工作的评审表示感谢。



重印和权限信息可在www.nature.com/reprints获取。



出版商的注意事项 斯普林格自然出版集团对发表的地图和机构所涉及的管辖权要求保持中立。



## 

---

 ## 原文[76/77]： 

  Springer Nature or its licensor (e.g. a society or other partner) holds  exclusive rights to this article under a publishing agreement with  the author(s) or other rightsholder(s); author self-archiving of the  accepted manuscript version of this article is solely governed by the  terms of such publishing agreement and applicable law. © Springer Nature Limited 2023  

---

 ## 翻译[76/77]：
 

### 版权声明



Springer Nature或其授权方（例如学会或其他合作伙伴）在与作者或其他权利持有人签订的出版协议下，拥有本文章的独家权利；对于该文章的已接受手稿版本的作者自行归档，仅受此类出版协议和适用法律的约束。© Springer Nature Limited 2023



